MSH|^~\&|||||20141130||VXU^V04^VXU_V04|742380-C1.001.3633|D|2.5.1|PID|1||742380-C1.001^^^OIS-TEST^MR||Logan^Trent^P^^^^L||20091211|M||2106-3^White^HL70005|100 Champaign Pl^^Warren^MI^48397^USA^P||^PRN^PH^^^586^5338726|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Z04H471.1^OIS|RXA|0|1|20101212||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101212||||||F|ORC|RE||Z04H471.2^OIS|RXA|0|1|20110706||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z04H471.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||VXU||VXU^V04^VXU_V04|742380-C1.002.4109|D|2.5.1|PID|1||742380-C1.002^^^OIS-TEST^MR||Burleson^Genesis^Bliss^^^^L||20091125|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|146 Plumas St^^Wells^MI^49894^USA^P||^PRN^PH^^^906^7898957|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||T86P472.1^OIS|RXA|0|1|20101121||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101121||||||F|ORC|RE||T86P472.2^OIS|RXA|0|1|20110624||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||T86P472.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||||VXU^V04^VXU_V04|742380-C1.003.4339|D|2.5.1|PID|1||742380-C1.003^^^OIS-TEST^MR||Cameron^Kamryn^^^^^L||20091126|F||2106-3^White^HL70005|78 Garfield Ave^^Allenton^MI^48002^USA^P||^PRN^PH^^^810^7954678|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S55O473.1^OIS|RXA|0|1|20101125||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101125||||||F|ORC|RE||S55O473.2^OIS|RXA|0|1|20110630||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S55O473.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104434-0700||VXU^TRIGGER^VXU_V04|742380-C1.004.4857|D|2.5.1|PID|1||742380-C1.004^^^OIS-TEST^MR||Louisa^Rahel^Xanthe^^^^L||20091115|F||2106-3^White^HL70005|332 Knott Ave^^Novi Township^MI^48375^USA^P||^PRN^PH^^^248^3499712|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||G51N474.1^OIS|RXA|0|1|20101122||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||G51N474.2^OIS|RXA|0|1|20110625||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G51N474.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104435-0700||^V04^VXU_V04|742380-C1.005.5315|D|2.5.1|PID|1||742380-C1.005^^^OIS-TEST^MR||Gustafson^Kingsley^Aidan^^^^L||20091205|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|273 Gannon Pl^^Clarksville^MI^48815^USA^P||^PRN^PH^^^616^8833227|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||P53W475.1^OIS|RXA|0|1|20101206||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101206||||||F|ORC|RE||P53W475.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P53W475.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||O6387ZU||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104435-0700||TYPE^V04^VXU_V04|742380-C1.006.5561|D|2.5.1|PID|1||742380-C1.006^^^OIS-TEST^MR||Dauphin^Rikin^Karter^^^^L||20091209|M||2131-1^Other Race^HL70005|400 Saunders Ln^^Grand Rapids^MI^49519^USA^P||^PRN^PH^^^616^9805585|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||C43B476.1^OIS|RXA|0|1|20101204||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||C43B476.2^OIS|RXA|0|1|20110701||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C43B476.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|PID|1||742380-C1.007^^^OIS-TEST^MR||Mahood^Jaidon^T^^^^L||20091130|M||2106-3^White^HL70005|164 Kinney Cir^^Cedar Springs^MI^49319^USA^P||^PRN^PH^^^616^2628099|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||O50V477.1^OIS|RXA|0|1|20101203||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||O50V477.2^OIS|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O50V477.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104435-0700||VXU^V04^VXU_V04|742380-C1.008.5592|D|2.5.1|PID|1||742380-C1.008^^^OIS-TEST^MR||Pierce^Godfrey^Yudhajit^^^^L||20091212|M||1002-5^American Indian or Alaska Native^HL70005|90 Camas Cir^^Howard City^MI^49329^USA^P||^PRN^PH^^^231^7281355|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||W87X478.1^OIS|RXA|0|1|20101213||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|ORC|RE||W87X478.2^OIS|RXA|0|1|20110707||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W87X478.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104436-0700||VXU^V04^VXU_V04|742380-C1.009.6083|D|2.5.1|PID|1||742380-C1.009^^^OIS-TEST^MR||Lake^Roz^M^^^^L||20091117|F||2054-5^Black or African-American^HL70005|284 Charlevoix Ave^^Stephenson^MI^49887^USA^P||^PRN^PH^^^906^7147060|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||T88L479.1^OIS|ORC|RE||T88L479.2^OIS|RXA|0|1|20101122||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||T88L479.3^OIS|RXA|0|1|20110627||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104436-0700||VXU^V04^VXU_V04|742380-C1.010.6283|D|2.5.1|ORC|RE||K00D480.1^OIS|RXA|0|1|20101208||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101208||||||F|ORC|RE||K00D480.2^OIS|RXA|0|1|20110706||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K00D480.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104436-0700||VXU^V04^VXU_V04|742380-C1.011.6485|D|2.5.1|PID|1||742380-C1.011^^^OIS-TEST^MR||Robertson^Sanjna^Lori^^^^L||20091130|F||2106-3^White^HL70005|172 Trinity Ln^^Ash Township^MI^48117^USA^P||^PRN^PH^^^734^2869515|||||||||2186-5^not Hispanic or Latino^CDCREC|PID|ORC|RE||H83E481.1^OIS|RXA|0|1|20101130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||H83E481.2^OIS|RXA|0|1|20110706||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||H83E481.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104437-0700||VXU^V04^VXU_V04|742380-C1.012.7358|D|2.5.1|PID|1||742380-C1.012^^^OIS-TEST^MR||Polk^Wyuna^K^^^^L||20091207|F||2106-3^White^HL70005|197 Hockley St^^Lakeville^MI^48366^USA^P||^PRN^PH^^^248^8645875|||||||||2186-5^not Hispanic or Latino^CDCREC|PV1|1|R|PV1|ORC|RE||Z38Z482.1^OIS|RXA|0|1|20101203||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||Z38Z482.2^OIS|RXA|0|1|20110627||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z38Z482.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W5169WY||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104438-0700||VXU^V04^VXU_V04|742380-C1.013.8754|D|2.5.1|PID|1||742380-C1.013^^^OIS-TEST^MR||Pedersen^Fluellen^Jedediah^^^^L||20091209|M||2106-3^White^HL70005|177 Knox St^^Walker^MI^49534^USA^P||^PRN^PH^^^616^4298071|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||B65T483.1^OIS|RXR|OTH|OBX|OBX|OBX|OBX|ORC|RE||B65T483.2^OIS|ORC|RE||B65T483.3^OIS|RXA|0|1|20101205||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|MSH|^~\&|||||20131130104438-0700||VXU^V04^VXU_V04|742380-C1.014.8922|D|2.5.1|PID|1||742380-C1.014^^^OIS-TEST^MR||Collingsworth^Tiki^N^^^^L||20091129|M||2106-3^White^HL70005|22 Cumberland Ln^^1^MI^48060^USA^P||^PRN^PH^^^810^2173069|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R59J484.1^OIS|RXA|0|1|20101203||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S2309FF||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||R59J484.2^OIS|RXA|0|1|20110704||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R59J484.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104439-0700||VXU^V04^VXU_V04|742380-C1.015.9408|D|2.5.1|PID|1||742380-C1.015^^^OIS-TEST^MR||Piscataquis^Jarrah^^^^^L||20091201|M||2106-3^White^HL70005|103 Skagit St^^^MI^48722^USA^P||^PRN^PH^^^989^7751928|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||W85M485.1^OIS|RXA|0|1|20101204||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||W85M485.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W85M485.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104439-0700||VXU^V04^VXU_V04|742380-C1.016.9867|D|2.5.1|PID|1||742380-C1.016^^^OIS-TEST^MR||Coal^Feodore^Tinh^^^^L||20091122|M||2054-5^Black or African-American^HL70005|^^^^^^^^^^^^^||^PRN^PH^^^517^6950563|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I59B486.1^OIS|RXA|0|1|20101128||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||I59B486.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I59B486.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104440-0700||VXU^V04^VXU_V04|742380-C1.017.365|D|2.5.1|PID|1||742380-C1.017^^^OIS-TEST^MR||Washington^Muhammad^A^^^^L||20091122|M||2106-3^White^HL70005|354 Menard Ave^^Bloomfield^^48303^USA^P||^PRN^PH^^^248^7871267|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||E05W487.1^OIS|RXA|0|1|20101126||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101126||||||F|ORC|RE||E05W487.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E05W487.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104440-0700||VXU^V04^VXU_V04|742380-C1.018.799|D|2.5.1|PID|1||742380-C1.018^^^OIS-TEST^MR||Hawke^Xanthe^Greer^^^^L||20091125|F||1002-5^American Indian or Alaska Native^HL70005|14 Beckham Ave^^Burt Lake^103^49717^USA^P||^PRN^PH^^^231^4823414|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||U82M488.1^OIS|RXA|0|1|20101123||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101123||||||F|ORC|RE||U82M488.2^OIS|RXA|0|1|20110628||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||U82M488.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104441-0700||VXU^V04^VXU_V04|742380-C1.019.1276|D|2.5.1|PID|1||742380-C1.019^^^OIS-TEST^MR||Vargas^Evie^Agnes^^^^L||20091128|F||2106-3^White^HL70005|^^Niles^MI^49120^USA^P||^PRN^PH^^^269^8310396|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Q79W489.1^OIS|RXA|0|1|20101128||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||Q79W489.2^OIS|RXA|0|1|20110704||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Q79W489.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104442-0700||VXU^V04^VXU_V04|742380-C1.020.2049|D|2.5.1|PID|1||742380-C1.020^^^OIS-TEST^MR||Sherman^Vedette^N^^^^L||20091115|F||2106-3^White^HL70005|355 Van Buren St^^Green Oak Township^MI^^USA^P||^PRN^PH^^^810^7052078|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||G42M490.1^OIS|RXA|0|1|20101119||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101119||||||F|ORC|RE||G42M490.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G42M490.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104442-0700||VXU^V04^VXU_V04|742380-C1.021.2510|D|2.5.1|PID|1||742380-C1.021^^^OIS-TEST^MR||Heffernan^Arden^D^^^^L||20141130|F||2054-5^Black or African-American^HL70005|253 Highland Cir^^Bath^MI^48808^USA^P||^PRN^PH^^^517^3048272|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||P96H491.1^OIS|RXA|0|1|20101127||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||P96H491.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P96H491.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104442-0700||VXU^V04^VXU_V04|742380-C1.022.2956|D|2.5.1|PID|1||742380-C1.022^^^OIS-TEST^MR||Benewah^Skyler^D^^^^L||20141130|F||2054-5^Black or African-American^HL70005|279 Comanche Cir^^Battle Creek^MI^49037^USA^P||^PRN^PH^^^269^6433121|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Y92X492.1^OIS|RXA|0|1|20101203||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||Y92X492.2^OIS|RXA|0|1|20110703||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Y92X492.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104443-0700||VXU^V04^VXU_V04|742380-C1.023.3407|D|2.5.1|PID|1||742380-C1.023^^^OIS-TEST^MR||Washington^Reman^Kitty^^^^L||DOB|F||2106-3^White^HL70005|297 Larssen St^^Port Huron Township^MI^48060^USA^P||^PRN^PH^^^810^3559396|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||I24W493.1^OIS|RXA|0|1|20101123||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101123||||||F|ORC|RE||I24W493.2^OIS|RXA|0|1|20110625||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I24W493.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104443-0700||VXU^V04^VXU_V04|742380-C1.024.3557|D|2.5.1|PID|1||742380-C1.024^^^OIS-TEST^MR||Bristol^India^L^^^^L|||F||2106-3^White^HL70005|151 Merwik Ave^^Lansing^MI^48911^USA^P||^PRN^PH^^^517^5927906|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||W25B494.1^OIS|RXA|0|1|20101124||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||W25B494.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W25B494.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104444-0700||VXU^V04^VXU_V04|742380-C1.025.4099|D|2.5.1|PID|1||742380-C1.025^^^OIS-TEST^MR||Gratiot^Neddie^Winston^^^^L||18950115|M||2106-3^White^HL70005|204 Richardson Cir^^Grosse Ile^MI^48138^USA^P||^PRN^PH^^^734^7700135|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S43N495.1^OIS|RXA|0|1|20101129||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||S43N495.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S43N495.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104445-0700||VXU^V04^VXU_V04|742380-C1.026.5381|D|2.5.1|PID|1||742380-C1.026^^^OIS-TEST^MR||Plumas^Roderick^Stoddard^^^^L||20091203|M||2054-5^Black or African-American^HL70005|380 Stevens Ave^^Nunica^MI^49448^USA^P||^PRN^PH^^^616^7871370|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||19500101|Y|ORC|RE||X70J496.1^OIS|RXA|0|1|20101128||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||X70J496.2^OIS|RXA|0|1|20110704||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||X70J496.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104445-0700||VXU^V04^VXU_V04|742380-C1.027.5993|D|2.5.1|PID|1||742380-C1.027^^^OIS-TEST^MR||Kalkaska^Shulamith^M^^^^L||20091121|M||2106-3^White^HL70005|22 Delaware Pl^^Lakewood Club^MI^49457^USA^P||^PRN^PH^^^231^9833842|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20141130|Y|ORC|RE||V05F497.1^OIS|RXA|0|1|20101121||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101121||||||F|ORC|RE||V05F497.2^OIS|RXA|0|1|20110625||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||V05F497.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104446-0700||VXU^V04^VXU_V04|742380-C1.028.6470|D|2.5.1|PID|1||742380-C1.028^^^OIS-TEST^MR||Delta^Dacia^N^^^^L||20091119|F||2106-3^White^HL70005|368 Colusa Cir^^Covington^MI^49919^USA^P||^PRN^PH^^^906^2023128|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||Y|Y|ORC|RE||Q19C498.1^OIS|RXA|0|1|20101120||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||Q19C498.2^OIS|RXA|0|1|20110625||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Q19C498.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104446-0700||VXU^V04^VXU_V04|742380-C1.029.6663|D|2.5.1|PID|1||742380-C1.029^^^OIS-TEST^MR||Dewey^Xander^Amir^^^^L||20091127|M||2106-3^White^HL70005|372 Yakima Pl^^Michiana^MI^49117^USA^P||^PRN^PH^^^269^6482799|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20131130|N|ORC|RE||C85V499.1^OIS|RXA|0|1|20101122||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||C85V499.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C85V499.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104447-0700||VXU^V04^VXU_V04|742380-C1.030.7323|D|2.5.1|PID|1||742380-C1.030^^^OIS-TEST^MR||Santa Cruz^Lisette^Ama^^^^L||20091209|F||2028-9^Asian^HL70005|202 Major Ave^^Buckley^MI^49620^USA^P||^PRN^PH^^^231^8966097|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20131130||ORC|RE||I78T500.1^OIS|RXA|0|1|20101209||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101209||||||F|ORC|RE||I78T500.2^OIS|RXA|0|1|20110705||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I78T500.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104447-0700||VXU^V04^VXU_V04|742380-C1.031.7857|D|2.5.1|PID|1||742380-C1.031^^^OIS-TEST^MR||Lubbock^Elmo^Gethin^^^^L||20091205|M||2106-3^White^HL70005|356 Madera Pl^^Lake Station^MI^48632^USA^P||^PRN^PH^^^989^3104857|||||||||^not Hispanic or Latino^CDCREC|ORC|RE||J08W501.1^OIS|RXA|0|1|20101203||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||J08W501.2^OIS|RXA|0|1|20110707||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||J08W501.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104448-0700||VXU^V04^VXU_V04|742380-C1.032.8556|D|2.5.1|PID|1||742380-C1.032^^^OIS-TEST^MR||Erie^Santos^Darcy^^^^L||20091206|M||2106-3^White^HL70005|168 Meredith Pl^^Big Rapids^MI^49307^USA^P||^PRN^PH^^^231^4501777|||||||||105 E Market St^not Hispanic or Latino^CDCREC|ORC|RE||L16E502.1^OIS|RXA|0|1|20101209||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101209||||||F|ORC|RE||L16E502.2^OIS|RXA|0|1|20110706||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||L16E502.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104450-0700||VXU^V04^VXU_V04|742380-C1.033.199|D|2.5.1|PID|1||742380-C1.033^^^OIS-TEST^MR||Cameron^Phyllis^Zan^^^^L||20091204|||2106-3^White^HL70005|115 Piscataquis Pl^^China Township^MI^48054^USA^P||^PRN^PH^^^810^2612964|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||G18F503.1^OIS|RXA|0|1|20101207||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101207||||||F|ORC|RE||G18F503.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G18F503.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||J6702KP||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104451-0700||VXU^V04^VXU_V04|742380-C1.034.1079|D|2.5.1|PID|1||742380-C1.034^^^OIS-TEST^MR||Coos^Ryder^Zaiden^^^^L||20091117|(404)555-3993||2106-3^White^HL70005|290 Alexanderson Cir^^Rodney^MI^49342^USA^P||^PRN^PH^^^231^2197115|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Z07W504.1^OIS|RXA|0|1|20101124||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||Z07W504.2^OIS|RXA|0|1|20110625||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z07W504.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104451-0700||VXU^V04^VXU_V04|742380-C1.035.1535|D|2.5.1|PID|1||742380-C1.035^^^OIS-TEST^MR||Hougen^Apt #5^Yuri^^^^L||20091204|M||2131-1^Other Race^HL70005|245 Roger Mills Ave^^Hillsdale^MI^49242^USA^P||^PRN^PH^^^517^7971062|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||M15O505.1^OIS|RXA|0|1|20101207||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101207||||||F|ORC|RE||M15O505.2^OIS|RXA|0|1|20110704||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M15O505.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104452-0700||VXU^V04^VXU_V04|742380-C1.036.2025|D|2.5.1|PID|1||742380-C1.036^^^OIS-TEST^MR||Warren^^Cameron^^^^L||20091130|M||2106-3^White^HL70005|225 Limestone St^^Harbor Springs^MI^49740^USA^P||^PRN^PH^^^616^3400506|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||U39F506.1^OIS|RXA|0|1|20101203||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||U39F506.2^OIS|RXA|0|1|20110703||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||U39F506.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4394LY||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104452-0700||VXU^V04^VXU_V04|742380-C1.037.2435|D|2.5.1|PID|1||742380-C1.037^^^OIS-TEST^MR||Mohave^John A^^^^^L||20091130|F||1002-5^American Indian or Alaska Native^HL70005|227 Hickman Ave^^West Bloomfield^MI^48325^USA^P||^PRN^PH^^^248^8762478|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Z54U507.1^OIS|RXA|0|1|20101124||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||Z54U507.2^OIS|RXA|0|1|20110628||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z54U507.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104452-0700||VXU^V04^VXU_V04|742380-C1.038.2976|D|2.5.1|PID|1||742380-C1.038^^^OIS-TEST^MR||Apt #5^Rihanna^^^^^L||20091129|F||2106-3^White^HL70005|351 Mason Ln^^Detroit^MI^48216^USA^P||^PRN^PH^^^313^5827219|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||O38M508.1^OIS|RXA|0|1|20101202||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||O38M508.2^OIS|RXA|0|1|20110707||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O38M508.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104453-0700||VXU^V04^VXU_V04|742380-C1.039.3847|D|2.5.1|PID|1||742380-C1.039^^^OIS-TEST^MR||^Perri^L^^^^L||20091123|M||2106-3^White^HL70005|341 San Juan Cir^^Luna Pier^MI^48157^USA^P||^PRN^PH^^^734^6757034|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Z91G509.1^OIS|RXA|0|1|20101127||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||Z91G509.2^OIS|RXA|0|1|20110701||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z91G509.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104455-0700||VXU^V04^VXU_V04|742380-C1.040.5708|D|2.5.1|PID|1||742380-C1.040^^^OIS-TEST^MR||Plymouth^NEWBORN^Hamlet^^^^L||20091122|M||2054-5^Black or African-American^HL70005|288 Hancock Ln^^Croswell^MI^48422^USA^P||^PRN^PH^^^810^6771679|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||M85E510.1^OIS|RXA|0|1|20101124||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||M85E510.2^OIS|RXA|0|1|20110627||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M85E510.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104456-0700||VXU^V04^VXU_V04|742380-C1.041.6489|D|2.5.1|PID|1||742380-C1.041^^^OIS-TEST^MR||TEST^Machi^Leilah^^^^L||20091201|F||2106-3^White^HL70005|213 Beecher Pl^^Midland^MI^48670^USA^P||^PRN^PH^^^989^6160536|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Q77H511.1^OIS|RXA|0|1|20101130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||Q77H511.2^OIS|RXA|0|1|20110629||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Q77H511.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||J6702KP||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104457-0700||VXU^V04^VXU_V04|742380-C1.042.7011|D|2.5.1|PID|1||742380-C1.042^^^OIS-TEST^MR||Clark^Joo-Chan^^^^^L||20091126|M||1002-5^American Indian or Alaska Native^HL70005|97 Colusa Pl^^Union Pier^MI^49129^USA^P||^PRN^PH^^^269^5520491|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1||||||||||||Y|ORC|RE||U78I512.1^OIS|RXA|0|1|20101125||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101125||||||F|ORC|RE||U78I512.2^OIS|RXA|0|1|20110630||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||U78I512.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104457-0700||VXU^V04^VXU_V04|742380-C1.043.7460|D|2.5.1|PID|1||^^^^^^^^||York^Minka^L^^^^L||20091205|F||2054-5^Black or African-American^HL70005|66 Clive St^^Detroit^MI^48277^USA^P||^PRN^PH^^^313^8384153|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||N21W513.1^OIS|RXA|0|1|20101206||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101206||||||F|ORC|RE||N21W513.2^OIS|RXA|0|1|20110706||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||N21W513.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104457-0700||VXU^V04^VXU_V04|742380-C1.044.7870|D|2.5.1|PID|1||742380-C1.044^^^OIS-TEST^MR||Dight^Cannon^Skelton^^^^L||20091202|M||2106-3^White^HL70005|294 Chambers Ln^^Detroit^MI^48223^USA^P||^PRN^PH^^^313^3144539|||||||||2186-5^not Hispanic or Latino^CDCREC|PV1|1|R||||||||||||||||||V02^19700101|ORC|RE||A03R514.1^OIS|RXA|0|1|20101204||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||A03R514.2^OIS|RXA|0|1|20110706||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A03R514.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104458-0700||VXU^V04^VXU_V04|742380-C1.045.8342|D|2.5.1|PID|1||742380-C1.045^^^OIS-TEST^MR||Geauga^Farnell^Jacques^^^^L||20091212|M||2054-5^Black or African-American^HL70005|289 Northampton St^^Treetops Village^MI^49735^USA^P||^PRN^PH^^^989^3651184|||||||||2186-5^not Hispanic or Latino^CDCREC|PV1|1|R||||||||||||||||||V02^20141130|ORC|RE||J90G515.1^OIS|RXA|0|1|20101211||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101211||||||F|ORC|RE||J90G515.2^OIS|RXA|0|1|20110705||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||J90G515.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104459-0700||VXU^V04^VXU_V04|742380-C1.046.9190|D|2.5.1|PID|1||742380-C1.046^^^OIS-TEST^MR||Hooker^Joesa^O^^^^L||20091127|F||2054-5^Black or African-American^HL70005|307 Alofson Pl^^Bruce Township^MI^48065^USA^P||^PRN^PH^^^586^2820070|||||||||2186-5^not Hispanic or Latino^CDCREC|PV1|1|R||||||||||||||||||V02^Y|ORC|RE||A80G516.1^OIS|RXA|0|1|20101129||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||A80G516.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A80G516.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104459-0700||VXU^V04^VXU_V04|742380-C1.047.9368|D|2.5.1|PID|1||742380-C1.047^^^OIS-TEST^MR||Nowata^Dymphna^Emely^^^^L||20091208|F||2106-3^White^HL70005|347 Beaver St^^Wyoming^MI^49519^USA^P||^PRN^PH^^^616^3722496|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||A40O517.1^OIS|RXA|0|1|20101202||01^DTP^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||A40O517.2^OIS|RXA|0|1|20110626||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A40O517.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104459-0700||VXU^V04^VXU_V04|742380-C1.048.9784|D|2.5.1|PID|1||742380-C1.048^^^OIS-TEST^MR||King^Cairistiona^Opal^^^^L||20091119|F||2106-3^White^HL70005|333 Greenlee Ave^^Birmingham^MI^48009^USA^P||^PRN^PH^^^248^7547600|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||F45L518.1^OIS|RXA|0|1|20101121||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101121||||||F|ORC|RE||F45L518.2^OIS|RXA|0|1|20110623||^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||F45L518.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104501-0700||VXU^V04^VXU_V04|742380-C1.049.1077|D|2.5.1|PID|1||742380-C1.049^^^OIS-TEST^MR||Madison^Jennifer^Jarita^^^^L||20091203|F||2131-1^Other Race^HL70005|265 Wilson Pl^^Lake Linden^MI^49945^USA^P||^PRN^PH^^^906^7612022|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K53V519.1^OIS|RXA|0|1|20101204||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||K53V519.2^OIS|RXA|0|1|20110704||PCV^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K53V519.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104501-0700||VXU^V04^VXU_V04|742380-C1.050.1919|D|2.5.1|PID|1||742380-C1.050^^^OIS-TEST^MR||King^Lorene^Annie^^^^L||20091129|F||2106-3^White^HL70005|183 Clarke Ln^^Lansing^MI^48951^USA^P||^PRN^PH^^^517^6742434|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A71T520.1^OIS|RXA|0|1|20101130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||A71T520.2^OIS|RXA|0|1|20141130||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A71T520.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104502-0700||VXU^V04^VXU_V04|742380-C1.051.2407|D|2.5.1|PID|1||742380-C1.051^^^OIS-TEST^MR||Clay^Stanko^Finley^^^^L||20091130|M||2054-5^Black or African-American^HL70005|297 Banner Pl^^Luna Pier^MI^48157^USA^P||^PRN^PH^^^734^2459216|||||||||2186-5^not Hispanic or Latino^CDCREC|||||||20091130|Y|ORC|RE||Y34B521.1^OIS|RXA|0|1|20101204||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||Y34B521.2^OIS|RXA|0|1|20110701||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Y34B521.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104503-0700||VXU^V04^VXU_V04|742380-C1.052.3042|D|2.5.1|PID|1||742380-C1.052^^^OIS-TEST^MR||Petterson^Lotte^Myah^^^^L||20091129|F||2054-5^Black or African-American^HL70005|57 O'Brian Pl^^Stanwood^MI^49346^USA^P||^PRN^PH^^^231^8057471|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A16Q522.1^OIS|RXA|0|1|20101130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||A16Q522.2^OIS|RXA|0|1|20110630||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|20091129|ORC|RE||A16Q522.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F9956NG||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104503-0700||VXU^V04^VXU_V04|742380-C1.053.3559|D|2.5.1|PID|1||742380-C1.053^^^OIS-TEST^MR||Mecosta^Seldon^^^^^L||20091202|M||2028-9^Asian^HL70005|17 Keya Paha St^^Troy^MI^48007^USA^P||^PRN^PH^^^248^7312803|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||C38K523.1^OIS|RXA|0|1|20101208||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S2309FF||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101208||||||F|ORC|RE||C38K523.2^OIS|RXA|0|1|19700101||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C38K523.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104506-0700||VXU^V04^VXU_V04|742380-C1.054.6954|D|2.5.1|PID|1||742380-C1.054^^^OIS-TEST^MR||Pike^Jaxton^Mervin^^^^L||20091122|M||2106-3^White^HL70005|13 Reagan Cir^^Iron Mountain^MI^49802^USA^P||^PRN^PH^^^906^6602466|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S68N524.1^OIS|RXA|0|1|20101124||01^DTP^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||S68N524.2^OIS|RXA|0|1|20110630||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S68N524.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104507-0700||VXU^V04^VXU_V04|742380-C1.055.7610|D|2.5.1|PID|1||742380-C1.055^^^OIS-TEST^MR||Caddo^Bhuvan^Mansur^^^^L||20091203|M||2028-9^Asian^HL70005|177 Marshall Ln^^Kingston^MI^48741^USA^P||^PRN^PH^^^989^4833358|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||M32U525.1^OIS|RXA|0|1|20101208||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101208||||||F|ORC|RE||M32U525.2^OIS|RXA|0|1|MMR||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M32U525.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104507-0700||VXU^V04^VXU_V04|742380-C1.056.7981|D|2.5.1|PID|1||742380-C1.056^^^OIS-TEST^MR||McQuade^Alvita^Leoma^^^^L||20091204|F||2106-3^White^HL70005|203 Union Cir^^Acme^MI^49610^USA^P||^PRN^PH^^^231^4541528|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||G61E526.1^OIS|RXA|0|1|20101205||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||G61E526.2^OIS|RXA|0|1|||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G61E526.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104508-0700||VXU^V04^VXU_V04|742380-C1.057.8451|D|2.5.1|PID|1||742380-C1.057^^^OIS-TEST^MR||Crane^Shipton^Edwin^^^^L||20091210|M||2106-3^White^HL70005|25 Evans Ave^^Yale^MI^48097^USA^P||^PRN^PH^^^810^5029668|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||L02G527.1^OIS|RXA|0|1|20101210||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101210||||||F|ORC|RE||L02G527.2^OIS|RXA|0|1|20110707||21^Varicella^CVX|999|||01^Historical^NIP001|||||||||||MMR|A|ORC|RE||L02G527.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K4394LY||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104508-0700||VXU^V04^VXU_V04|742380-C1.058.8959|D|2.5.1|PID|1||742380-C1.058^^^OIS-TEST^MR||Fleming^Cory^Christelle^^^^L||20091124|F||2106-3^White^HL70005|269 Calhoun Ln^^Canton^MI^48188^USA^P||^PRN^PH^^^734^3956224|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R61K528.1^OIS|RXA|0|1|20101129||^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||R61K528.2^OIS|RXA|0|1|20110630||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R61K528.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104509-0700||VXU^V04^VXU_V04|742380-C1.059.9415|D|2.5.1|PID|1||742380-C1.059^^^OIS-TEST^MR||Olsson^Bem^^^^^L||20091207|M||1002-5^American Indian or Alaska Native^HL70005|69 Dakota St^^Jasper^MI^49248^USA^P||^PRN^PH^^^517^8379594|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Z59H529.1^OIS|RXA|0|1|20101130||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||Z59H529.2^OIS|RXA|0|1|20110630||21^Varicella^CVX|999|||01^Historical^NIP001||^^^||||||||||A|ORC|RE||Z59H529.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104509-0700||VXU^V04^VXU_V04|742380-C1.060.9911|D|2.5.1|PID|1||742380-C1.060^^^OIS-TEST^MR||Dixon^Wright^Terje^^^^L||20091203|M||2028-9^Asian^HL70005|150 McErlaine St^^Bruce Township^MI^48065^USA^P||^PRN^PH^^^586^3740090|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||P99M530.1^OIS|RXA|0|1|20101205||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V00^VFC eligibility unknown^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||P99M530.2^OIS|RXA|0|1|20110630||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P99M530.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104510-0700||VXU^V04^VXU_V04|742380-C1.061.557|D|2.5.1|PID|1||742380-C1.061^^^OIS-TEST^MR||Island^Claire^Seanna^^^^L||20091115|F||1002-5^American Indian or Alaska Native^HL70005|303 Bremer Pl^^Elsie^MI^48831^USA^P||^PRN^PH^^^989^7346901|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Z83C531.1^OIS|RXA|0|1|20101118||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|^^||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101118||||||F|ORC|RE||Z83C531.2^OIS|RXA|0|1|20110624||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z83C531.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104511-0700||VXU^V04^VXU_V04|742380-C1.062.1121|D|2.5.1|PID|1||742380-C1.062^^^OIS-TEST^MR||Peterson^Fleance^A^^^^L||20091122|M||2106-3^White^HL70005|47 Dallas Pl^^Onaway^MI^49765^USA^P||^PRN^PH^^^989^7823490|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I46X532.1^OIS|RXA|0|1|20101122||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|ZZZ01^VFC Eligible^||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||I46X532.2^OIS|RXA|0|1|20110624||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I46X532.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104511-0700||VXU^V04^VXU_V04|742380-C1.063.1933|D|2.5.1|PID|1||742380-C1.063^^^OIS-TEST^MR||McCusker^Neal^A^^^^L||20091207|M||2131-1^Other Race^HL70005|380 Clermont Ln^^Lansing^MI^48956^USA^P||^PRN^PH^^^517^2656783|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K79I533.1^OIS|RXA|0|1|20101205||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||K79I533.2^OIS|RXA|0|1|20110705||21^Varicella^CVX|999|||^^||||||||||||A|ORC|RE||K79I533.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104512-0700||VXU^V04^VXU_V04|742380-C1.064.2385|D|2.5.1|PID|1||742380-C1.064^^^OIS-TEST^MR||Oakland^Kylan^Y^^^^L||20091129|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|63 Adams Ln^^Frankenmuth^MI^48787^USA^P||^PRN^PH^^^989^4718437|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||X66A534.1^OIS|RXA|0|1|20101202||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||X66A534.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|999|||LA-SC^Historical^NIP001||||||||||||A|ORC|RE||X66A534.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104513-0700||VXU^V04^VXU_V04|742380-C1.065.3019|D|2.5.1|PID|1||742380-C1.065^^^OIS-TEST^MR||Winterman^Kathryn^^^^^L||20091205|F||2106-3^White^HL70005|242 Luce Pl^^Total Petroleum^MI^48802^USA^P||^PRN^PH^^^989^9524217|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A63J535.1^OIS|RXA|0|1|20101203||02^OPV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||WAL^Wyeth^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||A63J535.2^OIS|RXA|0|1|20110630||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A63J535.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104514-0700||VXU^V04^VXU_V04|742380-C1.066.4637|D|2.5.1|PID|1||742380-C1.066^^^OIS-TEST^MR||Leelanau^Carmita^Maye^^^^L||20091208|F||2106-3^White^HL70005|292 Carter Ln^^Casnovia^MI^49318^USA^P||^PRN^PH^^^231^7912915|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Y28R536.1^OIS|RXA|0|1|20101204||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||Y28R536.2^OIS|RXA|0|1|20110707||141^Influenza^CVX|999|||01^Historical^NIP001|||||||||00^Parental Decision||CP|A|ORC|RE||Y28R536.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104515-0700||VXU^V04^VXU_V04|742380-C1.067.5110|D|2.5.1|PID|1||742380-C1.067^^^OIS-TEST^MR||Grant^Innocentia^^^^^L||20091114|F||2106-3^White^HL70005|196 Hardeman Ln^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^2657086|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||H05W537.1^OIS|RXA|0|1|20101121||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101121||||||F|ORC|RE||H05W537.2^OIS|RXA|0|1|20110626||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|20141130|ORC|RE||H05W537.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104515-0700||VXU^V04^VXU_V04|742380-C1.068.5790|D|2.5.1|PID|1||742380-C1.068^^^OIS-TEST^MR||Inyo^Adrian^^^^^L||20091115|M||2106-3^White^HL70005|275 Hardeman Pl^^Lenox^MI^48048^USA^P||^PRN^PH^^^586^7492037|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||K62B538.1^OIS|RXA|0|1|20101117||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101117||||||F|ORC|RE||K62B538.2^OIS|RXA|0|1|20110623||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|Harvey|ORC|RE||K62B538.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104515-0700||VXU^V04^VXU_V04|742380-C2.001.5958|D|2.5.1|||SOMETIMES|PID|1||742380-C2.001^^^OIS-TEST^MR||Grant^Welby^Gassy^^^^L||20091205|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|324 Wayne Ave^^Spalding^MI^49886^USA^P||^PRN^PH^^^906^5763309|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||J25H539.1^OIS|RXA|0|1|20101208||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101208||||||F|ORC|RE||J25H539.2^OIS|RXA|0|1|20110704||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||J25H539.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104516-0700||VXU^V04^VXU_V04|742380-C2.002.6442|D|2.5.1||||Monday|PID|1||742380-C2.002^^^OIS-TEST^MR||Fulton^Lance^Beacan^^^^L||20091217|M||2106-3^White^HL70005|318 Kalkaska Pl^^GR^MI^49525^USA^P||^PRN^PH^^^616^8664555|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I82G540.1^OIS|RXA|0|1|20101212||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I5629BK||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101212||||||F|ORC|RE||I82G540.2^OIS|RXA|0|1|20110706||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I82G540.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104517-0700||VXU^V04^VXU_V04||D|2.5.1|PID|1||742380-C2.003^^^OIS-TEST^MR||Ennis^Kaylyn^Karuah^^^^L||20091125|F||2106-3^White^HL70005|204 Garvin St^^Freedom Township^MI^48118^USA^P||^PRN^PH^^^734^3373539|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||D28H541.1^OIS|RXA|0|1|20101124||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W5169WY||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||D28H541.2^OIS|RXA|0|1|20110629||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D28H541.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104517||VXU^V04^VXU_V04|742380-C2.004.7705|D|2.5.1|PID|1||742380-C2.004^^^OIS-TEST^MR||Court^Luke^^^^^L||20091123|M||2106-3^White^HL70005|14 Ogemaw Cir^^Greenwood Township^MI^48006^USA^P||^PRN^PH^^^810^3474875|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||W61R542.1^OIS|RXA|0|1|20101124||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||W61R542.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W61R542.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130||VXU^V04^VXU_V04|742380-C2.005.8390|D|2.5.1|PID|1||742380-C2.005^^^OIS-TEST^MR||Cuyahoga^Fayna^^^^^L||20091120|F||2131-1^Other Race^HL70005|382 McLean Ln^^Belmont^MI^49306^USA^P||^PRN^PH^^^616^8926257|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||N86B543.1^OIS|RXA|0|1|20101126||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101126||||||F|ORC|RE||N86B543.2^OIS|RXA|0|1|20110625||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||N86B543.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104518-0700||VXU^V04^|742380-C2.006.8896|D|2.5.1|PID|1||742380-C2.006^^^OIS-TEST^MR||Sabine^Dryden^Vasuman^^^^L||20091209|M||2106-3^White^HL70005|164 Love St^^Grant^MI^49327^USA^P||^PRN^PH^^^231^5216878|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I31L544.1^OIS|RXA|0|1|20101209||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101209||||||F|ORC|RE||I31L544.2^OIS|RXA|0|1|20110705||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I31L544.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F9956NG||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104519-0700||VXU^V04^STRUCTURE|742380-C2.007.9547|D|2.5.1|PID|1||742380-C2.007^^^OIS-TEST^MR||Hubbard^Dustin^Diarmid^^^^L||20091124|M||2106-3^White^HL70005|21 Lyastrom Pl^^Saint Clr Shrs^MI^48081^USA^P||^PRN^PH^^^586^9025073|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||W72K545.1^OIS|RXA|0|1|20101123||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101123||||||F|ORC|RE||W72K545.2^OIS|RXA|0|1|20110624||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W72K545.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104519-0700||VXU^^VXU_V04|742380-C2.008.9986|D|2.5.1|PID|1||742380-C2.008^^^OIS-TEST^MR||Tetlow^Janina^Tallulah^^^^L||20091202|F||2106-3^White^HL70005|396 McPherson Cir^^Fairview^MI^48621^USA^P||^PRN^PH^^^989^4587865|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||R01T546.1^OIS|RXA|0|1|20101208||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101208||||||F|ORC|RE||R01T546.2^OIS|RXA|0|1|20110701||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R01T546.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104520-0700||VXU^V04^VXU_V04|742380-C2.009.815|PROD|2.5.1|PID|1||742380-C2.009^^^OIS-TEST^MR||Lucas^Joab^^^^^L||20091205|M||2106-3^White^HL70005|247 Kent Cir^^Washington^MI^48095^USA^P||^PRN^PH^^^586^7806547|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K83F547.1^OIS|RXA|0|1|20101204||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||K83F547.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K83F547.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104521-0700||VXU^V04^VXU_V04|742380-C2.010.1549|D||PID|1||742380-C2.010^^^OIS-TEST^MR||Luce^Morven^Ayasha^^^^L||20091123|F||2106-3^White^HL70005|256 MontmorencyMuskegon Ln^^Trenton^MI^48183^USA^P||^PRN^PH^^^734^9286341|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||P99E548.1^OIS|RXA|0|1|20101122||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||P99E548.2^OIS|RXA|0|1|20110627||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P99E548.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104522-0700||VXU^V04^VXU_V04|742380-C2.011.2337|D|13.4|PID|1||742380-C2.011^^^OIS-TEST^MR||Monroe^Manilla^Kaja^^^^L||20091128|F||2106-3^White^HL70005|28 Galveston Pl^^Port Huron^MI^48060^USA^P||^PRN^PH^^^810^7364448|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R83N549.1^OIS|RXA|0|1|20101128||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||R83N549.2^OIS|RXA|0|1|20110623||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R83N549.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104522-0700||VXU^V04^VXU_V04|742380-C2.012.2956|D|2.3.1|PID|1||742380-C2.012^^^OIS-TEST^MR||Hill^Kush^Adoni^^^^L||20091201|M||2106-3^White^HL70005|119 Lokken Ln^^Paradise^MI^49768^USA^P||^PRN^PH^^^906^2173768|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||W02I550.1^OIS|RXA|0|1|20101205||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||W02I550.2^OIS|RXA|0|1|20110705||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W02I550.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104523-0700||VXU^V04^VXU_V04|742380-C2.013.3598|D|2.4|PID|1||742380-C2.013^^^OIS-TEST^MR||Tuolumne^Tara^C^^^^L||20091205|M||2106-3^White^HL70005|289 Ulseth Ln^^Muskegon^MI^49442^USA^P||^PRN^PH^^^231^4558674|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Y08K551.1^OIS|RXA|0|1|20101128||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||Y08K551.2^OIS|RXA|0|1|20110627||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Y08K551.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104524-0700||VXU^V04^VXU_V04|742380-C2.014.4087|D|2.5.1|PID|1||742380-C2.014^^^OIS-TEST^MR||Parkes^Paisley^T^^^^L||20091127|F||1002-5^American Indian or Alaska Native^HL70005|320 Thomas St^^GR^MI^49514^USA^P||^PRN^PH^^^616^3309763|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||T31B552.1^OIS|RXA|0|1|20101124||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||T31B552.2^OIS|RXA|0|1|20110625||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||T31B552.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104524-0700||VXU^V04^VXU_V04|742380-C2.015.4963|D|2.5.1|PID|1||742380-C2.015^^^OIS-TEST^MR||Nordby^Smriti^Marcia^^^^L||20091121|F||2106-3^White^HL70005|241 Greene Cir^^Simplicity Pattern^MI^49121^USA^P||^PRN^PH^^^269^5944573|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||D72H553.1^OIS|RXA|0|1|20101122||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||D72H553.2^OIS|RXA|0|1|20110626||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D72H553.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104526-0700||VXU^V04^VXU_V04|742380-C2.016.6880|D|2.5.1|PID|1||742380-C2.016^^^OIS-TEST^MR||Throckmorton^Karishma^Gita^^^^L||20091202|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|257 Nelson St^^Beaverton^MI^48612^USA^P||^PRN^PH^^^989^3141308|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K25H554.1^OIS|RXA||1|20101201||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||K25H554.2^OIS|RXA|0|1|20110705||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K25H554.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104527-0700||VXU^V04^VXU_V04|742380-C2.017.7299|D|2.5.1|PID|1||742380-C2.017^^^OIS-TEST^MR||Iosco^Hare^Vaclav^^^^L||20091127|M||1002-5^American Indian or Alaska Native^HL70005|53 Turner Ln^^Orchard Lake^MI^48323^USA^P||^PRN^PH^^^248^8595480|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A54X555.1^OIS|RXA|0|1|20101203||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||A54X555.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A54X555.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104527-0700||VXU^V04^VXU_V04|742380-C2.018.7800|D|2.5.1|PID|1||742380-C2.018^^^OIS-TEST^MR||Sheridan^Haig^M^^^^L||20091120|M||2106-3^White^HL70005|96 Lie Cir^^Carsonville^MI^48419^USA^P||^PRN^PH^^^810^4790708|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||G37Z556.1^OIS|RXA|0|1|20101127||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|RXR|OTH|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||G37Z556.2^OIS|RXA|0|1|20110704||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G37Z556.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104528-0700||VXU^V04^VXU_V04|742380-C2.019.8597|D|2.5.1|PID|1||742380-C2.019^^^OIS-TEST^MR||Pawnee^Fear^^^^^L||20091205|M||2106-3^White^HL70005|310 Edwards St^^Lansing^MI^48924^USA^P||^PRN^PH^^^517^6880423|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Johnsson^Syshe|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^ANYTOWN|^PRN^PH^^^517^6880423|ORC|RE||P32H557.1^OIS|RXA|0|1|20101206||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101206||||||F|ORC|RE||P32H557.2^OIS|RXA|0|1|20110629||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P32H557.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104529-0700||VXU^V04^VXU_V04|742380-C2.020.9068|D|2.5.1|PID|1||742380-C2.020^^^OIS-TEST^MR||Franklin^Salim^J^^^^L||20091203|M||2054-5^Black or African-American^HL70005|355 Christian Ave^^Vassar^MI^48768^USA^P||^PRN^PH^^^989^8144238|||||||||2135-2^Hispanic or Latino^CDCREC|NK1|1|Franklin^Corinne|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^|^PRN^PH^^^989^8144238|ORC|RE||U34A558.1^OIS|RXA|0|1|20101201||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||U34A558.2^OIS|RXA|0|1|20110629||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||U34A558.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104529-0700||VXU^V04^VXU_V04|742380-C2.021.9536|D|2.5.1|PID|1||742380-C2.021^^^OIS-TEST^MR||Adams^Faraji^Denver^^^^L||20091201|M||2106-3^White^HL70005|36 Lemhi Ln^^Bloomingdale^MI^49026^USA^P||^PRN^PH^^^269^3009619|||||||||2135-2^Hispanic or Latino^CDCREC|NK1|1|Carson^Orane|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^This is an unexpectedly long name for a city|^PRN^PH^^^269^3009619|ORC|RE||B24A559.1^OIS|RXA|0|1|20101124||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||B24A559.2^OIS|RXA|0|1|20110630||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||B24A559.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104529-0700||VXU^V04^VXU_V04|742380-C2.022.9972|D|2.5.1|PID|1||742380-C2.022^^^OIS-TEST^MR||Boyd^Kristal^^^^^L||20091125|F||2054-5^Black or African-American^HL70005|150 Lyon St^^Lakewood Club^MI^49457^USA^P||^PRN^PH^^^231^9906102|||||||||2135-2^Hispanic or Latino^CDCREC|NK1|1|Armstrong^Mikaela|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^^SOMETHING|^PRN^PH^^^231^9906102|ORC|RE||J25I560.1^OIS|RXA|0|1|20101128||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||O6387ZU||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||J25I560.2^OIS|RXA|0|1|20110701||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||J25I560.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F9956NG||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104530-0700||VXU^V04^VXU_V04|742380-C2.023.441|D|2.5.1|PID|1||742380-C2.023^^^OIS-TEST^MR||Rock^Lissa^^^^^L||20091202|F||2106-3^White^HL70005|79 Cameron Cir^^Brownstown Township^MI^48173^USA^P||^PRN^PH^^^734^9783188|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Mifflin^Chhavvi|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^^^^^County|^PRN^PH^^^734^9783188|ORC|RE||L51Z561.1^OIS|RXA|0|1|20101130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||J6702KP||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||L51Z561.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||L51Z561.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104531-0700||VXU^V04^VXU_V04|742380-C2.024.1158|D|2.5.1|PID|1||742380-C2.024^^^OIS-TEST^MR||Osceola^Morna^Kloe^^^^L||20091117|F||2106-3^White^HL70005|242 O'Neill Pl^^Utica^MI^48318^USA^P||^PRN^PH^^^586^7162000|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Teton^Sharon|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^^^|^PRN^PH^^^586^7162000|ORC|RE||V00H562.1^OIS|RXA|0|1|20101116||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101116||||||F|ORC|RE||V00H562.2^OIS|RXA|0|1|20110623||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||V00H562.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104531-0700||VXU^V04^VXU_V04|742380-C2.025.1597|D|2.5.1|PID|1||742380-C2.025^^^OIS-TEST^MR||Cruz^Marcelo^^^^^L||20091130|M||2106-3^White^HL70005|198 Umatilla St^^Riverdale^MI^48877^USA^P||^PRN^PH^^^989^2325826|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Cruz^Fanchon|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^Mass|^PRN^PH^^^989^2325826|ORC|RE||D42G563.1^OIS|RXA|0|1|20101124||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5629BK||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||D42G563.2^OIS|RXA|0|1|20110629||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D42G563.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104532-0700||VXU^V04^VXU_V04|742380-C2.026.2531|D|2.5.1|PID|1||742380-C2.026^^^OIS-TEST^MR||Thornley^Dame^A^^^^L||20091126|F||2054-5^Black or African-American^HL70005|281 Muscatine Ave^^Livonia^MI^48153^USA^P||^PRN^PH^^^734^2867044|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|MontmorencyMuskegon^Enye|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^^^PRIMARY|^PRN^PH^^^734^2867044|ORC|RE||E52T564.1^OIS|RXA|0|1|20101129||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||E52T564.2^OIS|RXA|0|1|20110629||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E52T564.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104533-0700||VXU^V04^VXU_V04|742380-C2.027.3093|D|2.5.1|PID|1||742380-C2.027^^^OIS-TEST^MR||Clare^Uren^Skene^^^^L||20091128|M||2106-3^White^HL70005|118 Sutherns Cir^^Rochester Hls^MI^48309^USA^P||^PRN^PH^^^248^9465869|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Brown^Genette|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^^^BA|^PRN^PH^^^248^9465869|ORC|RE||T40E565.1^OIS|RXA|0|1|20101201||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||T40E565.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||T40E565.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104533-0700||VXU^V04^VXU_V04|742380-C2.028.3681|D|2.5.1|PID|1||742380-C2.028^^^OIS-TEST^MR||Nelsen^Florian^Hansel^^^^L||20091117|M||2054-5^Black or African-American^HL70005|391 Valley Ave^^Lincoln Park^MI^48146^USA^P||^PRN^PH^^^313^4811850|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Noble^Suvarna|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^9o21o|^PRN^PH^^^313^4811850|ORC|RE||Z89C566.1^OIS|RXA|0|1|20101119||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4394LY||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101119||||||F|ORC|RE||Z89C566.2^OIS|RXA|0|1|20110624||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z89C566.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104534-0700||VXU^V04^VXU_V04|742380-C2.029.4294|D|2.5.1|PID|1||742380-C2.029^^^OIS-TEST^MR||Roach^Akshay^Hylton^^^^L||20091130|M||2054-5^Black or African-American^HL70005|249 Menominee St^^Bay City^MI^48710^USA^P||^PRN^PH^^^989^9888410|||||||||2135-2^Hispanic or Latino^CDCREC|NK1|1|Roach^Eirwen|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^9o21o|^PRN^PH^^^989^9888410|ORC|RE||O37E567.1^OIS|RXA|0|1|20101127||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||O37E567.2^OIS|RXA|0|1|20110703||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O37E567.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||O6387ZU||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104535-0700||VXU^V04^VXU_V04|742380-C2.030.5033|D|2.5.1|PID|1||742380-C2.030^^^OIS-TEST^MR||Hickman^Daren^Kalani^^^^L||20091126|M||2106-3^White^HL70005|250 Whatcom Ave^^Northwest^MI^48531^USA^P||^PRN^PH^^^810^7322953|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Runnels^|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=||^PRN^PH^^^810^7322953|ORC|RE||O96R568.1^OIS|RXA|0|1|20101201||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||O96R568.2^OIS|RXA|0|1|20110626||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O96R568.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||J6702KP||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104535-0700||VXU^V04^VXU_V04|742380-C2.031.5462|D|2.5.1|PID|1||742380-C2.031^^^OIS-TEST^MR||Bell^Arashel^Rainbow^^^^L||20091114|F||2106-3^White^HL70005|154 Terrell Ave^^Bloomfield Hills^MI^48304^USA^P||^PRN^PH^^^248^2180396|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|^|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=||^PRN^PH^^^248^2180396|ORC|RE||M44Q569.1^OIS|RXA|0|1|20101121||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101121||||||F|ORC|RE||M44Q569.2^OIS|RXA|0|1|20110626||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M44Q569.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104536-0700||VXU^V04^VXU_V04|742380-C2.032.6024|D|2.5.1|PID|1||742380-C2.032^^^OIS-TEST^MR||Owyhee^Alize^Alisha^^^^L||20091219|F||2054-5^Black or African-American^HL70005|162 Jackson Pl^^Trout Lake^MI^49793^USA^P||^PRN^PH^^^906^9104859|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|^Thomasa|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=||^PRN^PH^^^906^9104859|ORC|RE||P46K570.1^OIS|RXA|0|1|20101214||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101214||||||F|ORC|RE||P46K570.2^OIS|RXA|0|1|20110707||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P46K570.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104536-0700||VXU^V04^VXU_V04|742380-C2.033.6611|D|2.5.1|PID|1||742380-C2.033^^^OIS-TEST^MR||Hamilton^Severina^Jacqueline^^^^L||20091202|F||2054-5^Black or African-American^HL70005|99 Morris Cir^^Bessemer^MI^49911^USA^P||^PRN^PH^^^906^9516389|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Trumbull^Lucine|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=||^PRN^PH^^^^9516389|ORC|RE||K86M571.1^OIS|RXA|0|1|20101129||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||K86M571.2^OIS|RXA|0|1|20110623||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K86M571.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104537-0700||VXU^V04^VXU_V04|742380-C2.034.7112|D|2.5.1|PID|1||742380-C2.034^^^OIS-TEST^MR||Kearney^Bo^^^^^L||20091129|M||2106-3^White^HL70005|150 Luzerne Pl^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^5430262|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Westport^Vienna|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=||^PRN^PH^^^APPLE GATE^5430262|ORC|RE||O23U572.1^OIS|RXA|0|1|20101201||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||O23U572.2^OIS|RXA|0|1|20110625||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O23U572.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104539-0700||VXU^V04^VXU_V04|742380-C2.035.9044|D|2.5.1|PID|1||742380-C2.035^^^OIS-TEST^MR||Nelsen^Cayden^L^^^^L||20091128|M||2054-5^Black or African-American^HL70005|333 Gosper Ln^^Richmond Township^MI^48062^USA^P||^PRN^PH^^^586^9054563|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|O'Neill^Carolena|^^||^PRN^PH^^^586^9054563|ORC|RE||B78L573.1^OIS|RXA|0|1|20101125||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101125||||||F|ORC|RE||B78L573.2^OIS|RXA|0|1|20110629||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||B78L573.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104539-0700||VXU^V04^VXU_V04|742380-C2.036.9499|D|2.5.1|PID|1||742380-C2.036^^^OIS-TEST^MR||Templeman^Tangaroa^Whitby^^^^L||20091124|M||2106-3^White^HL70005|211 Glenn Ave^^Southfield^MI^48033^USA^P||^PRN^PH^^^248^4685829|||||||||2135-2^Hispanic or Latino^CDCREC|NK1|1|Edmonson^Blake|CHD^Child||^PRN^PH^^^248^4685829|ORC|RE||N01B574.1^OIS|RXA|0|1|20101129||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||N01B574.2^OIS|RXA|0|1|20110704||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||N01B574.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104540-0700||VXU^V04^VXU_V04|742380-C2.037.242|D|2.5.1|PID|1||742380-C2.037^^^OIS-TEST^MR||Miami^Sulwyn^Yair^^^^L||20091125|M||2054-5^Black or African-American^HL70005|280 Franklin St^^Grosse Pointe Park^MI^48236^USA^P||^PRN^PH^^^313^7188143|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Adams^Alula|CHD^Child||^PRN^PH^^^313^7188143|ORC|RE||P07D575.1^OIS|RXA|0|1|20101202||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||P07D575.2^OIS|RXA|0|1|20110704||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P07D575.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104540-0700||VXU^V04^VXU_V04|742380-C2.038.673|D|2.5.1|PID|1||742380-C2.038^^^OIS-TEST^MR||Scott^Luca^V^^^^L||20091205|M||1002-5^American Indian or Alaska Native^HL70005|104 Owyhee Ln^^Bloomfield^MI^48304^USA^P||^PRN^PH^^^248^8224640|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Wardle^Odette|DS^Dog Sitter||^PRN^PH^^^248^8224640|ORC|RE||B35L576.1^OIS|RXA|0|1|20101202||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4394LY||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||B35L576.2^OIS|RXA|0|1|20110707||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||B35L576.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104541-0700||VXU^V04^VXU_V04|742380-C2.039.1609|D|2.5.1|PID|1||742380-C2.039^^^OIS-TEST^MR||Harrison^Sushma^Amarina^^^^L||20091208|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|151 Protheroe Ln^^Meskegon^MI^49444^USA^P||^PRN^PH^^^231^6279921|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||S95S577.1^OIS|RXA|0|1|20101201||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||S95S577.2^OIS|RXA|0|1|20110707||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S95S577.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S2309FF||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104542-0700||VXU^V04^VXU_V04|742380-C2.040.2100|D|2.5.1|PID|1||742380-C2.040^^^OIS-TEST^MR||Lake^Stanfield^Hansi^^^^L||20091130|M||2106-3^White^HL70005|303 Latah St^^Peck^MI^48466^USA^P||^PRN^PH^^^810^9394573|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||E81T578.1^OIS|RXA|0|1|20101128||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||E81T578.2^OIS|RXA|0|1|20110626||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E81T578.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104542-0700||VXU^V04^VXU_V04|742380-C2.041.2772|D|2.5.1|PID|1||742380-C2.041^^^OIS-TEST^MR||Monon^Rocky^Skene^^^^L||20091117|M||2106-3^White^HL70005|276 Bolgen Ln^^Boardwalk^MI^48638^USA^P||^PRN^PH^^^989^7793190|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||E80K579.1^OIS|RXA|0|1|20101117||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|LOINC GOES HERE^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101117||||||F|ORC|RE||E80K579.2^OIS|RXA|0|1|20110624||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E80K579.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104543-0700||VXU^V04^VXU_V04|742380-C2.042.3252|D|2.5.1|PID|1||742380-C2.042^^^OIS-TEST^MR||Coleman^Ripley^Rarna^^^^L||20091119|M||2106-3^White^HL70005|115 Calaveras St^^Dearborn Heights^MI^48125^USA^P||^PRN^PH^^^313^5853186|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||F88R580.1^OIS|RXA|0|1|20101120||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||F88R580.2^OIS|RXA|0|1|20110623||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||F88R580.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104543-0700||VXU^V04^VXU_V04|742380-C2.043.3974|D|2.5.1|PID|1||742380-C2.043^^^OIS-TEST^MR||Bolgen^Nolene^Mora^^^^L||20091127|F||1002-5^American Indian or Alaska Native^HL70005|206 Delaware Cir^^Bannister^MI^48807^USA^P||^PRN^PH^^^989^7582756|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||T43R581.1^OIS|RXA|0|1|20101203||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1||64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||T43R581.2^OIS|RXA|0|1|20110704||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||T43R581.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104544-0700||VXU^V04^VXU_V04|742380-C2.044.4526|D|2.5.1|PID|1||742380-C2.044^^^OIS-TEST^MR||Ocario^Rere^Beau^^^^L||20091123|F||2106-3^White^HL70005|190 Iosco Ln^^Trufant^MI^49347^USA^P||^PRN^PH^^^231^9736903|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I36G582.1^OIS|RXA|0|1|20101130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CODED VALUE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||I36G582.2^OIS|RXA|0|1|20110704||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I36G582.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104545-0700||VXU^V04^VXU_V04|742380-C2.045.5236|D|2.5.1|PID|1||742380-C2.045^^^OIS-TEST^MR||Teton^Mertice^T^^^^L||20091201|F||2106-3^White^HL70005|159 Ingham Cir^^This is an unexpectedly long name for a city^MI^48045^USA^P||^PRN^PH^^^586^9928879|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||D88E583.1^OIS|RXA|0|1|20101205||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||J6702KP||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||D88E583.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D88E583.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104545-0700||VXU^V04^VXU_V04|742380-C2.046.5845|D|2.5.1|PID|1||742380-C2.046^^^OIS-TEST^MR||Yakima^Phuong^Pierce^^^^L||20091124|M||2054-5^Black or African-American^HL70005|242 Sequoyah Cir^^Nisula^MI^49952^US of A^P||^PRN^PH^^^906^2408683|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||E04P584.1^OIS|RXA|0|1|20101201||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||E04P584.2^OIS|RXA|0|1|20110705||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E04P584.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104546-0700||VXU^V04^VXU_V04|742380-C2.048.6502|D|2.5.1|PID|1||742380-C2.048^^^OIS-TEST^MR||Nolan^Christmas^Hortensius^^^^L||20091214|M||2054-5^Black or African-American^HL70005|82 Lee Ln^^GR^MI^49509^USA^||^PRN^PH^^^616^5134199|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||C48G586.1^OIS|RXA|0|1|20101211||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101211||||||F|ORC|RE||C48G586.2^OIS|RXA|0|1|20110704||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C48G586.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104547-0700||VXU^V04^VXU_V04|742380-C2.049.7451|D|2.5.1|PID|1||742380-C2.049^^^OIS-TEST^MR||San Luis Obispo^Lydia^Inger^^^^L||20091127|F||2106-3^White^HL70005|86 Cumberland Cir^^Pittsfield Township^MI^48104^USA^PRIMARY||^PRN^PH^^^734^4060751|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||N78G587.1^OIS|RXA|0|1|20101201||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||N78G587.2^OIS|RXA|0|1|20110627||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||N78G587.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104547-0700||VXU^V04^VXU_V04|742380-C2.051.7926|D|2.5.1|PID|1||742380-C2.051^^^OIS-TEST^MR||Power^Desdemona^^^^^L||20091216|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|84 Knight Ln^^Greenwood^MI^50^USA^P||^PRN^PH^^^810^8783748|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||M80U589.1^OIS|RXA|0|1|20101212||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101212||||||F|ORC|RE||M80U589.2^OIS|RXA|0|1|20110706||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M80U589.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104548-0700||VXU^V04^VXU_V04|742380-C2.052.8411|D|2.5.1|PID|1||742380-C2.052^^^OIS-TEST^MR||Navarro^Vincenzo^^^^^L||20091121|M||2106-3^White^HL70005|176 Sarpy Ave^^Alpena^MI^49707^USA^P||^PRN^PH^^^989^8163642|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||C45F590.1^OIS|RXA|0|1|20101120||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||C45F590.2^OIS|RXA|0|1|20110625||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C45F590.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104549-0700||VXU^V04^VXU_V04|742380-C2.053.9155|D|2.5.1|PID|1||742380-C2.053^^^OIS-TEST^MR||Paso^Stoddard^Forbes^^^^L||20091211|M||2106-3^White^HL70005|349 Vistanst Pl^^GR^MI^49506^USA^P||^PRN^PH^^^616^8916678|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||E83B591.1^OIS|RXA|0|1|20101204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||E83B591.2^OIS|RXA|0|1|20110701||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E83B591.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104550-0700||VXU^V04^VXU_V04|742380-C2.054.128|D|2.5.1|PID|1||742380-C2.054^^^OIS-TEST^MR||King^Taksa^R^^^^L||20091126|M||2106-3^White^HL70005|40 Madison St^^Essexville^MI^48732^USA^P||^PRN^PH^^^989^3622620|||||||||2186-5^not Hispanic or Latino^CDCREC||X|ORC|RE||V89Y592.1^OIS|RXA|0|1|20101119||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101119||||||F|ORC|RE||V89Y592.2^OIS|RXA|0|1|20110624||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||V89Y592.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104550-0700||VXU^V04^VXU_V04|742380-C2.055.613|D|2.5.1|PID|1||742380-C2.055^^^OIS-TEST^MR||Grant^Molly^Precious^^^^L||20091205|F||2131-1^Other Race^HL70005|397 Boundary Ave^^Shelby^MI^49455^USA^P||^PRN^PH^^^231^5532298|||||||||2135-2^Hispanic or Latino^CDCREC||Y|Twin|ORC|RE||G22H593.1^OIS|RXA|0|1|20101130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||G22H593.2^OIS|RXA|0|1|20110625||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G22H593.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104551-0700||VXU^V04^VXU_V04|742380-C2.056.1123|D|2.5.1|PID|1||742380-C2.056^^^OIS-TEST^MR||Dight^Elliot^V^^^^L||20091213|M||2106-3^White^HL70005|2 San Bernardino Pl^^Detroit^MI^48244^USA^P||^PRN^PH^^^313^9351309|||||||||2186-5^not Hispanic or Latino^CDCREC||Y||ORC|RE||L07J594.1^OIS|RXA|0|1|20101207||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101207||||||F|ORC|RE||L07J594.2^OIS|RXA|0|1|20110707||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||L07J594.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104552-0700||VXU^V04^VXU_V04|742380-C2.057.2013|D|2.5.1|PID|1||742380-C2.057^^^OIS-TEST^MR||Jack^Vijay^Dai^^^^L||20091128|M||2131-1^Other Race^HL70005|398 Andersen Pl^^Flint^MI^48554^USA^P||^PRN^PH^^^810^8790446|||||||||2186-5^not Hispanic or Latino^CDCREC||ORC|RE||Q06F595.1^OIS|RXA|0|1|20101129||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||Q06F595.2^OIS|RXA|0|1|20110706||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Q06F595.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104552-0700||VXU^V04^VXU_V04|742380-C2.059.2685|D|2.5.1|PID|1||742380-C2.059^^^OIS-TEST^MR||Holingson^Kloe^^^^^L||20091122|F||1002-5^American Indian or Alaska Native^HL70005|172 Tuolumne Ave^^Michiana^MI^49117^USA^P||^PRN^PH^^^269^4650277|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||H31R597.1^OIS|RXA|0|1|20101127||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||H31R597.2^OIS|RXA|0|1|20110623||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||H31R597.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104553-0700||VXU^V04^VXU_V04|742380-C2.060.3119|D|2.5.1|PID|1||742380-C2.060^^^OIS-TEST^MR||Gallia^Zazu^Kasimir^^^^L||20091201|M||2054-5^Black or African-American^HL70005|212 Smith St^^Highland^MI^48356^USA^P||^PRN^PH^^^248^7081286|||||||||2186-5^not Hispanic or Latino^CDCREC||||||||Y|ORC|RE||X26N598.1^OIS|RXA|0|1|20101206||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5629BK||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101206||||||F|ORC|RE||X26N598.2^OIS|RXA|0|1|20110706||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||X26N598.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F9956NG||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104553-0700||VXU^V04^VXU_V04|742380-C2.061.3722|D|2.5.1|PID|1||742380-C2.061^^^OIS-TEST^MR||Ainslie^Gamble^S^^^^L||20091118|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|198 Page Pl^^Dearborn^MI^48128^USA^P||^PRN^PH^^^313^6063602|||||||||H^not Hispanic or Latino^CDCREC|ORC|RE||R62F599.1^OIS|RXA|0|1|20101125||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101125||||||F|ORC|RE||R62F599.2^OIS|RXA|0|1|20110701||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R62F599.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104554-0700||VXU^V04^VXU_V04|742380-C2.062.4472|D|2.5.1|PID|1||742380-C2.062^^^OIS-TEST^MR||Red Willow^Doug^A^^^^L||20091207|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|103 Dallas Cir^^Brownstwn Township^MI^48183^USA^P||^PRN^PH^^^734^4540240|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||J43U600.1^OIS|RXA|0|1|20101201||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||J43U600.2^OIS|RXA|0|1|20110628||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||J43U600.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104555-0700||VXU^V04^VXU_V04|742380-C2.063.5258|D|2.5.1|PID|1||742380-C2.063^^^OIS-TEST^MR||Skamania^Marilyn^Teresa^^^^L||20091130|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|104 Lamar Ave^^Acme^MI^49610^USA^P||^PRN^PH^^^231^8579146|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||U34S601.1^OIS|RXA|0|1|20101130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||U34S601.2^OIS|RXA|0|1|20110629||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||U34S601.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104556-0700||VXU^V04^VXU_V04|742380-C2.064.6267|D|2.5.1|PID|1||742380-C2.064^^^OIS-TEST^MR||Linn^Thurborn^Waine^^^^L||20091208|M||2054-5^Black or African-American^HL70005|320 Jensen Pl^^Saint Johns^MI^48879^USA^P||^PRN^PH^^^989^2370888|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||C89M602.1^OIS|RXA|0|1|20101203||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||C89M602.2^OIS|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C89M602.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104556-0700||VXU^V04^VXU_V04|742380-C2.065.6993|D|2.5.1|PID|1||742380-C2.065^^^OIS-TEST^MR||Midland^Shona^Aiyana^^^^L||20091206|F||2054-5^Black or African-American^HL70005|212 Ida Ln^^Berrien Sprgs^MI^49104^USA^P||^PRN^PH^^^269^9725283|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Q95N603.1^OIS|RXA|0|1|20101203||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||Q95N603.2^OIS|RXA|0|1|20110705||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Q95N603.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104557-0700||VXU^V04^VXU_V04|742380-C2.066.7597|D|2.5.1|PID|1||742380-C2.066^^^OIS-TEST^MR||Summresgill^Ushnisha^Kirkley^^^^L||20091124|M||2028-9^Asian^HL70005|140 Krog St^^Flint^MI^48554^USA^P||^PRN^PH^^^810^7334998|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||U52X604.1^OIS|RXA|0|1|20101128||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||U52X604.2^OIS|RXA|0|1|20110628||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||U52X604.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104558-0700||VXU^V04^VXU_V04|742380-C2.067.8432|D|2.5.1|PID|1||742380-C2.067^^^OIS-TEST^MR||Kootenai^Allie^S^^^^L||20091122|F||1002-5^American Indian or Alaska Native^HL70005|89 La Paz Cir^^Cement City^MI^49233^USA^P||^PRN^PH^^^517^3280208|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I55H605.1^OIS|RXA|0|1|20101127||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||I55H605.2^OIS|RXA|0|1|20110703||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I55H605.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||F9956NG||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104559-0700||VXU^V04^VXU_V04|742380-C2.068.9155|D|2.5.1|PID|1||742380-C2.068^^^OIS-TEST^MR||Penobscot^Luis^^^^^L||20091206|M||2106-3^White^HL70005|202 Carbon Ln^^Marquette^MI^49855^USA^P||^PRN^PH^^^906^9324162|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||V60Y606.1^OIS|RXA|0|1|20101202||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||V60Y606.2^OIS|RXA|0|1|20110705||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||V60Y606.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104559-0700||VXU^V04^VXU_V04|742380-C2.069.9649|D|2.5.1|PID|1||742380-C2.069^^^OIS-TEST^MR||Shappe^Lilia^Aiyana^^^^L||20091209|F||2131-1^Other Race^HL70005|130 Ulseth Ave^^Saint Heights^MI^48310^USA^P||^PRN^PH^^^586^3569843|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||R47H607.1^OIS|RXA|0|1|20101204||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||R47H607.2^OIS|RXA|0|1|20110629||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R47H607.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104600-0700||VXU^V04^VXU_V04|742380-C2.070.321|D|2.5.1|PID|1||742380-C2.070^^^OIS-TEST^MR||Isabella^Jendyose^G^^^^L||20091126|F||2106-3^White^HL70005|214 Clarion St^^Mayfield^MI^49666^USA^P||^PRN^PH^^^231^8046327|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||O03I608.1^OIS|RXA|0|1|20101120||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||O03I608.2^OIS|RXA|0|1|20110625||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O03I608.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4394LY||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104602-0700||VXU^V04^VXU_V04|742380-C2.071.2126|D|2.5.1|PID|1||742380-C2.071^^^OIS-TEST^MR||Madera^Adrienne^^^^^L||20091206|F||2054-5^Black or African-American^HL70005|214 Ottawa Ave^^Bloomfield^MI^48303^USA^P||^PRN^PH^^^248^4819445|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I93Y609.1^OIS|RXA|0|1|20101209||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101209||||||F|ORC|RE||I93Y609.2^OIS|RXA|0|1|20110706||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I93Y609.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104603-0700||VXU^V04^VXU_V04|742380-C2.072.3115|D|2.5.1|PID|1||742380-C2.072^^^OIS-TEST^MR||Sioux^Delwyn^B^^^^L||20091123|F||2106-3^White^HL70005|279 Henderson St^^Hamtramck^MI^48212^USA^P||^PRN^PH^^^313^4963002|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S88K610.1^OIS|RXA|0|1|20101124||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||S88K610.2^OIS|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S88K610.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104603-0700||VXU^V04^VXU_V04|742380-C2.073.3956|D|2.5.1|PID|1||742380-C2.073^^^OIS-TEST^MR||Clatsop^Javon^Ebrahim^^^^L||20091127|M||2054-5^Black or African-American^HL70005|172 Sanilac Pl^^Farmington^MI^48333^USA^P||^PRN^PH^^^248^2344469|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||V87M611.1^OIS|RXA|0|1|20101129||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||V87M611.2^OIS|RXA|0|1|20110705||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||V87M611.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104604-0700||VXU^V04^VXU_V04|742380-C2.074.4432|D|2.5.1|PID|1||742380-C2.074^^^OIS-TEST^MR||Ross^Jaelynn^^^^^L||20091115|F||2106-3^White^HL70005|7 Arthur Ln^^Big Rapids^MI^49307^USA^P||^PRN^PH^^^231^7611016|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||U27R612.1^OIS|RXA|0|1|20101122||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||U27R612.2^OIS|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||U27R612.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104605-0700||VXU^V04^VXU_V04|742380-C2.075.5090|D|2.5.1|PID|1||742380-C2.075^^^OIS-TEST^MR||Duval^Talib^This middle name is long^^^^L||20091125|M||2106-3^White^HL70005|140 Cimarron Ln^^Cedarville^MI^49719^USA^P||^PRN^PH^^^906^5984378|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S43N613.1^OIS|RXA|0|1|20101124||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||S43N613.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S43N613.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104605-0700||VXU^V04^VXU_V04|742380-C2.076.5626|D|2.5.1|PID|1||742380-C2.076^^^OIS-TEST^MR||Licking^Harriet^G^^^^L||20091129|F||2054-5^Black or African-American^HL70005|29 Lancaster St^^Birmingham^MI^48009^USA^P||^PRN^PH^^^248^3923138|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K38L614.1^OIS|RXA|0|1|20101205||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||K38L614.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K38L614.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104606-0700||VXU^V04^VXU_V04|742380-C2.077.6423|D|2.5.1|PID|1||742380-C2.077^^^OIS-TEST^MR||Forest^Beaumont^L^^^^L|This mothers name is much longer than expected|20091126|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|66 Columbia Ln^^Christian Reformed Church^MI^49560^USA^P||^PRN^PH^^^616^2447456|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||X33A615.1^OIS|RXA|0|1|20101129||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||X33A615.2^OIS|RXA|0|1|20110624||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||X33A615.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104606-0700||VXU^V04^VXU_V04|742380-C2.078.6924|D|2.5.1|PID|1||742380-C2.078^^^OIS-TEST^MR||Centre^Vivian^This first name is to long^^^^L||20091116|M||2106-3^White^HL70005|395 Hamilton Pl^^Eastpointe^MI^48021^USA^P||^PRN^PH^^^586^4178595|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||O09Z616.1^OIS|RXA|0|1|20101118||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101118||||||F|ORC|RE||O09Z616.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O09Z616.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W5169WY||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104607-0700||VXU^V04^VXU_V04|742380-C2.079.7603|D|2.5.1|PID|1||742380-C2.079^^^OIS-TEST^MR||Lincoln^Bertana^This last name is longer than expected^^^^L||20091120|F||2106-3^White^HL70005|82 Lucas Pl^^Jackson^MI^49201^USA^P||^PRN^PH^^^517^3660964|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||X18Y617.1^OIS|RXA|0|1|20101126||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101126||||||F|ORC|RE||X18Y617.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||X18Y617.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||O6387ZU||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104608-0700||VXU^V04^VXU_V04|742380-C2.080.8081|D|2.5.1|PID|1||742380-C2.080^^^OIS-TEST^MR||Hardeman^Allard^N^^^^A||20091201|M||2106-3^White^HL70005|180 Oldham St^^Lansing^MI^48918^USA^P||^PRN^PH^^^517^2812809|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||X33D618.1^OIS|RXA|0|1|20101201||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||X33D618.2^OIS|RXA|0|1|20110707||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||X33D618.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104608-0700||VXU^V04^VXU_V04|742380-C2.081.8536|D|2.5.1|PID|1||742380-C2.081^^^OIS-TEST^MR||Marsh^Gerome^Shrey^^^^Samuel||20091127|M||2106-3^White^HL70005|372 Wasco Ln^^DTE Energy Brm^MI^48269^USA^P||^PRN^PH^^^313^3045225|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||E41C619.1^OIS|RXA|0|1|20101204||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||E41C619.2^OIS|RXA|0|1|20110706||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E41C619.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104608-0700||VXU^V04^VXU_V04|742380-C2.082.8966|D|2.5.1|PID|1||742380-C2.082^^^OIS-TEST^MR||Santa Clara^Amund^^^^^L||20091203|M||2028-9^Asian^HL70005|365 Wheeler Pl^^Wyoming^MI^49519^USA^P||7059773^PRN^PH^^^^7059773|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||B55T620.1^OIS|RXA|0|1|20101203||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||B55T620.2^OIS|RXA|0|1|20110703||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||B55T620.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104609-0700||VXU^V04^VXU_V04|742380-C2.083.9416|D|2.5.1|PID|1||742380-C2.083^^^OIS-TEST^MR||Lapeer^Tanner^Mog^^^^L||20091207|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|155 Saunders St^^London Township^MI^48160^USA^P||104 E Market St^^Allegany^^^MI^04599|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||U74O621.1^OIS|RXA|0|1|20101204||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||U74O621.2^OIS|RXA|0|1|20110705||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||U74O621.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104609-0700||VXU^V04^VXU_V04|742380-C2.084.9927|D|2.5.1|PID|1||742380-C2.084^^^OIS-TEST^MR||Reeves^Winter^^^^^L||20091203|F||1002-5^American Indian or Alaska Native^HL70005|118 Banberg Pl^^Saginaw^MI^48602^USA^P||(989)9502530^PRN^BAD^^^989^9502530|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||X79X622.1^OIS|RXA|0|1|20101206||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101206||||||F|ORC|RE||X79X622.2^OIS|RXA|0|1|20110704||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||X79X622.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104610-0700||VXU^V04^VXU_V04|742380-C2.085.358|D|2.5.1|PID|1||742380-C2.085^^^OIS-TEST^MR||Marquette^Socrates^A^^^^L||20091121|M||2054-5^Black or African-American^HL70005|140 Woodbury Pl^^Seneca^MI^49256^USA^P||(517)5679267^Apt B^PH^^^517^5679267|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Q29Z623.1^OIS|RXA|0|1|20101124||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||Q29Z623.2^OIS|RXA|0|1|20110625||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Q29Z623.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104610-0700||VXU^V04^VXU_V04|742380-C2.086.824|D|2.5.1|PID|1||742380-C2.086^^^OIS-TEST^MR||Armstrong^Kyna^O^^^^L||20091117|F||2106-3^White^HL70005|289 Reagan Cir^^Jackson^MI^49203^USA^P||^PRN^PH^^^517^2592816||(555)555-1123|||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||D66H624.1^OIS|RXA|0|1|20101122||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||D66H624.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D66H624.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104611-0700||VXU^V04^VXU_V04|742380-C2.087.1843|D|2.5.1|PID|1||742380-C2.087^^^OIS-TEST^MR||Hussey^Suleiman^Sinnott^^^^L||20091129|M||2106-3^White^HL70005|280 Bakey Cir^^Auburn Hills^MI^48326^USA^P||^PRN^PH^^^248^2726638|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||J54A625.1^OIS|RXA|0|1|20101202||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||J54A625.2^OIS|RXA|0|1|20110707||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||J54A625.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104612-0700||VXU^V04^VXU_V04|742380-C2.088.2281|D|2.5.1|PID|1||742380-C2.088^^^OIS-TEST^MR||Forest^Jihan^E^^^^L||20091125|F||2106-3^White^HL70005|336 Menifee St^^Weston^MI^49289^USA^P||^PRN^PH^^^517^2678569|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||F47K626.1^OIS|RXA|0|1|20101126||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||J6702KP||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101126||||||F|ORC|RE||F47K626.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||F47K626.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104612-0700||VXU^V04^VXU_V04|742380-C2.089.2737|D|2.5.1|PID|1||742380-C2.089^^^OIS-TEST^MR||Grant^Holt^A^^^^L||20091211|M||2054-5^Black or African-American^HL70005|272 Clark Ave^^Levering^MI^49755^USA^P||^PRN^PH^^^616^6039219|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||B21H627.1^OIS|RXA|0|1|20101209||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101209||||||F|ORC|RE||B21H627.2^OIS|RXA|0|1|20110705||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||B21H627.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104614-0700||VXU^V04^VXU_V04|742380-C2.090.4297|D|2.5.1|PID|1||742380-C2.090^^^OIS-TEST^MR||Owen^Nerissa^Carna^^^^L||20091129|F||I^White^HL70005|66 Hogg St^^Oxford^MI^48370^USA^P||^PRN^PH^^^248^2757585|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I44I628.1^OIS|RXA|0|1|20101123||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101123||||||F|ORC|RE||I44I628.2^OIS|RXA|0|1|20110625||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I44I628.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104614-0700||VXU^V04^VXU_V04|742380-C2.091.4781|D|2.5.1|PID|1||742380-C2.091^^^OIS-TEST^MR||Titus^Yootha^Innocentia^^^^L||20091205|F||^White^HL70005|45 Crumbaker St^^Millbrook^MI^49310^USA^P||^PRN^PH^^^989^3207029|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Z39K629.1^OIS|RXA|0|1|20101202||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||Z39K629.2^OIS|RXA|0|1|20110630||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z39K629.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104615-0700||VXU^V04^VXU_V04|742380-C2.092.5524|D|2.5.1|PID|1||742380-C2.092^^^OIS-TEST^MR||Leslie^Saloni^S^^^^L||20091205|F||108 N Main St^White^HL70005|212 Fulton Ave^^Saginaw^MI^48609^USA^P||^PRN^PH^^^989^9126644|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||H11C630.1^OIS|RXA|0|1|20101205||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||H11C630.2^OIS|RXA|0|1|20110706||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||H11C630.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104616-0700||VXU^V04^VXU_V04|742380-C2.093.6008|D|2.5.1|PID|1||742380-C2.093^^^OIS-TEST^MR||McLennan^Naia^^^^^L||20091126|F||2106-3^White^HL70005|86 Bell Ln^^Cass City^MI^48726^USA^P||^PRN^PH^^^989^2362715|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||P78E631.1^OIS|RXA|0|1|20101202||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||P78E631.2^OIS|RXA|0|1|20110630||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P78E631.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104616-0700||VXU^V04^VXU_V04|742380-C2.094.6510|D|2.5.1|PID|1||742380-C2.094^^^OIS-TEST^MR~123456789^^^USA^SS||Lokken^Neil^^^^^L||20091205|M||2106-3^White^HL70005|342 Ronning St^^Rothbury^MI^49452^USA^P||^PRN^PH^^^231^5475954|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R36F632.1^OIS|RXA|0|1|20101130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||R36F632.2^OIS|RXA|0|1|20110705||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R36F632.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104617-0700||VXU^V04^VXU_V04|742380-C2.095.7018|D|2.5.1|PID|1||742380-C2.095^^^^MR||Berks^Sammy^S^^^^L||20091202|F||1002-5^American Indian or Alaska Native^HL70005|236 Appanoose Cir^^Melvin^MI^48454^USA^P||^PRN^PH^^^810^9807605|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Q89U633.1^OIS|RXA|0|1|20101201||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||Q89U633.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Q89U633.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104617-0700||VXU^V04^VXU_V04|742380-C2.096.7623|D|2.5.1|PID|1||742380-C2.096^^^OIS-TEST^||Okmulgee^Aparna^A^^^^L||20091130|F||2106-3^White^HL70005|317 Le Flore Pl^^Milford Township^MI^48381^USA^P||^PRN^PH^^^248^4476976|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||V64W634.1^OIS|RXA|0|1|20101124||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||V64W634.2^OIS|RXA|0|1|20110626||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||V64W634.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K4394LY||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104618-0700||VXU^V04^VXU_V04|742380-C2.097.8445|D|2.5.1|PID|1||742380-C2.097^^^OIS-TEST^MR||Union^Elwin^Candidius^^^^L||20091205|M||2106-3^White^HL70005|135 Benton Ave^^GR^MI^49548^USA^P||^PRN^PH^^^616^9225470|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A46J635.1^OIS|RXA|0|1|20101207||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101207||||||F|ORC|RE||A46J635.2^OIS|RXA|0|1|20110703||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A46J635.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F9956NG||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104618-0700||VXU^V04^VXU_V04|742380-C2.098.8899|D|2.5.1|PID|1||742380-C2.098^^^OIS-TEST^MR||Armstrong^Tarcal^V^^^^L||20091208|M||1002-5^American Indian or Alaska Native^HL70005|221 Van Zandt Ln^^Oakley^MI^48649^USA^P||^PRN^PH^^^989^9934126|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||D29P636.1^OIS|RXA|0|1|20101202||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||D29P636.2^OIS|RXA|0|1|20110704||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D29P636.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104619-0700||VXU^V04^VXU_V04|742380-C2.099.9562|D|2.5.1|PID|1||742380-C2.099^^^OIS-TEST^MR||Cumberland^Alouetta^Georgette^^^^L||20091208|F||2106-3^White^HL70005|252 Hobell Cir^^Sylvan Lake^MI^48320^USA^P||^PRN^PH^^^248^8109587|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||P86M637.1^OIS|RXA|0|1|20101202||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||P86M637.2^OIS|RXA|0|1|20110706||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P86M637.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104620-0700||VXU^V04^VXU_V04|742380-C2.100.82|D|2.5.1|PID|1||742380-C2.100^^^OIS-TEST^MR||Kiernan^Hylda^Danae^^^^L||20091129|F||2106-3^White^HL70005|43 Brennan Pl^^Saint Ignace^MI^49781^USA^P||^PRN^PH^^^906^3290198|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||C35D638.1^OIS|RXA|0|1|20101128||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||C35D638.2^OIS|RXA|0|1|20110624||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||20091129|ORC|RE||C35D638.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104620-0700||VXU^V04^VXU_V04|742380-C2.101.735|D|2.5.1|PID|1||742380-C2.101^^^OIS-TEST^MR||Dimmit^Taddeo^Kyler^^^^L||20091128|M||2106-3^White^HL70005|227 Gosper St^^Lansing^MI^48980^USA^P||^PRN^PH^^^517^5510108|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S47H639.1^OIS|RXA|0|1|20101202||45^Hep B, unspecified formulation^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||S47H639.2^OIS|RXA|0|1|20110707||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S47H639.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||O6387ZU||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104621-0700||VXU^V04^VXU_V04|742380-C2.102.1253|D|2.5.1|PID|1||742380-C2.102^^^OIS-TEST^MR||Monaghan^Xavier^G^^^^L||20091127|M||2106-3^White^HL70005|159 Rauma St^^Burtchville^MI^48059^USA^P||^PRN^PH^^^810^8540620|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||D04B640.1^OIS|RXA|0|1|20101129||71^RSV-IGIV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||D04B640.2^OIS|RXA|0|1|20110628||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D04B640.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104621-0700||VXU^V04^VXU_V04|742380-C2.103.1758|D|2.5.1|PID|1||742380-C2.103^^^OIS-TEST^MR||Scotts Bluff^Thanh^^^^^L||20091127|F||2106-3^White^HL70005|389 Montgomery Ln^^Stambaugh^MI^49964^USA^P||^PRN^PH^^^906^6954488|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Y67B641.1^OIS|RXA|0|1|20100301PID-7=20011010||100^pneumococcal conjugate PCV 7^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4394LY||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||Y67B641.2^OIS|RXA|0|1|20110625||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Y67B641.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104622-0700||VXU^V04^VXU_V04|742380-C2.104.2123|D|2.5.1|PID|1||742380-C2.104^^^OIS-TEST^MR||Greene^Blondelle^Vibhuti^^^^L||20091130|F||2054-5^Black or African-American^HL70005|396 Sac Pl^^Nashville^MI^49073^USA^P||^PRN^PH^^^517^3357832|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||J65G642.1^OIS|RXA|0|1|20101127||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||O6387ZU||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||J65G642.2^OIS|RXA|0|1|20110624||999^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||J65G642.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104622-0700||VXU^V04^VXU_V04|742380-C2.105.2644|D|2.5.1|PID|1||742380-C2.105^^^OIS-TEST^MR||Tere^Cory^Y^^^^L||20091203|M||2106-3^White^HL70005|252 Knox Cir^^Kinross^MI^49752^USA^P||^PRN^PH^^^906^8628788|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||T67J643.1^OIS|RXA|0|1|20101202||141^Influenza^CVX CODE|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||T67J643.2^OIS|RXA|0|1|20110625||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||T67J643.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104623-0700||VXU^V04^VXU_V04|742380-C2.106.3387|D|2.5.1|PID|1||742380-C2.106^^^OIS-TEST^MR||Comal^Aegea^R^^^^L||20091201|F||1002-5^American Indian or Alaska Native^HL70005|380 Wheeler Ave^^Moline^MI^49335^USA^P||^PRN^PH^^^616^4663713|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||P22X644.1^OIS|RXA|0|1|20101129||140^Influenza^|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5629BK||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||P22X644.2^OIS|RXA|0|1|20110704||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P22X644.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104624-0700||VXU^V04^VXU_V04|742380-C2.107.4000|D|2.5.1|PID|1||742380-C2.107^^^OIS-TEST^MR||Dundy^Aliyah^Rylie^^^^L||20091211|F||2106-3^White^HL70005|40 Poweshiek Ave^^Boyne City^MI^49712^USA^P||^PRN^PH^^^231^4969448|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Y97W645.1^OIS|RXA|0|1|20101210||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101210||||||F|ORC|RE||Y97W645.2^OIS|RXA|0|1|20110703|20091211|140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Y97W645.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104624-0700||VXU^V04^VXU_V04|742380-C2.108.4792|D|2.5.1|PID|1||742380-C2.108^^^OIS-TEST^MR||Union^Thistle^W^^^^L||20091121|F||2054-5^Black or African-American^HL70005|193 Dickinson Cir^^Skandia^MI^49885^USA^P||^PRN^PH^^^906^2978622|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||T46U646.1^OIS|RXA|0|1|20101117||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101117||||||F|ORC|RE||T46U646.2^OIS|RXA|0|1|20110624||141^Influenza^CVX|999|||01^Historical^NIP001|||||||20091121|||||A|ORC|RE||T46U646.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104626-0700||VXU^V04^VXU_V04|742380-C2.109.6653|D|2.5.1|PID|1||742380-C2.109^^^OIS-TEST^MR||Livingston^Pazia^Klara^^^^L||20091126|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|72 Muskingum Pl^^Detroit^MI^48267^USA^P||^PRN^PH^^^313^5394433|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||M78Y647.1^OIS|RXA|0|1|20100301PID-7=20011010||100^pneumococcal conjugate PCV 7^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||M78Y647.2^OIS|RXA|0|1|20110702||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M78Y647.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104626-0700||VXU^V04^VXU_V04|742380-C2.110.6853|D|2.5.1|PID|1||742380-C2.110^^^OIS-TEST^MR||Sweeney^Timur^P^^^^L||20091204|M||2106-3^White^HL70005|368 Farrell Cir^^Corunna^MI^48817^USA^P||^PRN^PH^^^989^9030389|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||N42O648.1^OIS|RXA|0|1|20101210||118^HPV, bivalent^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101210||||||F|ORC|RE||N42O648.2^OIS|RXA|0|1|20110707||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||N42O648.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S2309FF||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104627-0700||VXU^V04^VXU_V04|742380-C2.112.7388|D|2.5.1|PID|1||742380-C2.112^^^OIS-TEST^MR||Jessen^Cominius^Ordway^^^^L||20091203|M||2106-3^White^HL70005|379 Kinney Pl^^Delton^MI^49046^USA^P||^PRN^PH^^^269^2764921|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||W84S650.1^OIS|RXA|0|1|20101201||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||W84S650.2^OIS|RXA|0|1|20110629||140^Influenza^CVX|MMR|ML^^ISO+||01^Historical^NIP001||||||||||||A|ORC|RE||W84S650.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104627-0700||VXU^V04^VXU_V04|742380-C2.113.7934|D|2.5.1|PID|1||742380-C2.113^^^OIS-TEST^MR||Oscoda^Valter^Curio^^^^L||20091126|M||2054-5^Black or African-American^HL70005|237 Pima St^^Bloomfield Township^MI^48301^USA^P||^PRN^PH^^^248^9021403|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S27I651.1^OIS|RXA|0|1|20101127||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||S27I651.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|0.5|CM^^ISO+||01^Historical^NIP001||||||||||||A|ORC|RE||S27I651.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104628-0700||VXU^V04^VXU_V04|742380-C2.114.8804|D|2.5.1|PID|1||742380-C2.114^^^OIS-TEST^MR||Deuel^Geoffrey^Theon^^^^L||20091202|M||2106-3^White^HL70005|282 Jefferson Ave^^Casco^MI^48064^USA^P||^PRN^PH^^^810^4360880|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K61M652.1^OIS|RXA|0|1|20101206||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|IN^Intranasal^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101206||||||F|ORC|RE||K61M652.2^OIS|RXA|0|1|20110704||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K61M652.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104629-0700||VXU^V04^VXU_V04|742380-C2.116.9282|D|2.5.1|PID|1||742380-C2.116^^^OIS-TEST^MR||Ferry^Vitoria^Saige^^^^L||20091124|F||2106-3^White^HL70005|229 Jantti Pl^^Southfield^MI^48075^USA^P||^PRN^PH^^^248^9438950|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||G89M654.1^OIS|RXA|0|1|20101128||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|MMR^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||G89M654.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G89M654.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W5169WY||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104630-0700||VXU^V04^VXU_V04|742380-C2.118.32|D|2.5.1|PID|1||742380-C2.118^^^OIS-TEST^MR||Poweshiek^Reed^Thorgils^^^^L||20091122|M||2054-5^Black or African-American^HL70005|142 Monroe Ln^^Grandville^MI^49468^USA^P||^PRN^PH^^^616^4112703|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||D40L656.1^OIS|RXA|0|1|20101127||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|Jones Clinic^^|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||D40L656.2^OIS|RXA|0|1|20110703||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D40L656.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5629BK||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104630-0700||VXU^V04^VXU_V04|742380-C2.119.467|D|2.5.1|PID|1||742380-C2.119^^^OIS-TEST^MR||Newport^Prima^^^^^L||20091121|F||2054-5^Black or African-American^HL70005|56 Lemhi Ave^^Chrysler Corporation^MI^48288^USA^P||^PRN^PH^^^313^8071631|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||M99G657.1^OIS|RXA|0|1|20101124||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||M99G657.2^OIS|||||||||||||||||||||||||Block^^HL70177|RXA|0|1|20110623||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M99G657.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104630-0700||VXU^V04^VXU_V04|742380-C2.120.981|D|2.5.1|PID|1||742380-C2.120^^^OIS-TEST^MR||Jacinto^Armen^M^^^^L||20091126|M||2054-5^Black or African-American^HL70005|104 Canyon St^^Oakland Township^MI^48306^USA^P||^PRN^PH^^^248^3361148|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K44C658.1^OIS|RXA|0|1|20101203||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||K44C658.2^OIS|||||||||||||||||||||||||R^^HL70177|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K44C658.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104631-0700||VXU^V04^VXU_V04|742380-C2.127.1476|D|2.5.1|PID|1||742380-C2.127^^^OIS-TEST^MR||Johnston^Uttanka^Werner^^^^L||20091116|M||2106-3^White^HL70005|205 Iowa Pl^^Avoca^MI^48006^USA^P||^PRN^PH^^^810^4115003|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||T66K665.1^OIS|RXA|0|1|20101120||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^New immunization record^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||T66K665.2^OIS|RXA|0|1|20110625||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||T66K665.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104631-0700||VXU^V04^VXU_V04|742380-C2.128.1968|D|2.5.1|PID|1||742380-C2.128^^^OIS-TEST^MR||San Juan^Kulvir^Kelly^^^^L||20091203|M||2106-3^White^HL70005|101 Upton St^^Merriweather^MI^49947^USA^P||^PRN^PH^^^906^6855418|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R00I666.1^OIS|RXA|0|1|20101202||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||R00I666.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|999|||01^Historical information - source unspecified^NIP001||||||||||||A|ORC|RE||R00I666.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z0860BB||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104632-0700||VXU^V04^VXU_V04|742380-C2.129.2917|D|2.5.1|PID|1||742380-C2.129^^^OIS-TEST^MR||Hardin^Verena^Reyna^^^^L||20091126|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|264 Newaygo Ave^^Farmington^MI^48331^USA^P||^PRN^PH^^^248^6486397|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A54S667.1^OIS|RXA|0|1|20101201||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||A54S667.2^OIS|RXA|0|1|20110629||140^Influenza^CVX|999|||01^Historical^NIP001|||||||Never|||||A|ORC|RE||A54S667.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104633-0700||VXU^V04^VXU_V04|742380-C2.130.3780|D|2.5.1|PID|1||742380-C2.130^^^OIS-TEST^MR||Dickinson^Derick^A^^^^L||20091125|M||2106-3^White^HL70005|27 Throckmorton Ave^^Climax^MI^49034^USA^P||^PRN^PH^^^269^4491467|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||T77I668.1^OIS|RXA|0|1|20101119||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101119||||||F|ORC|RE||T77I668.2^OIS|RXA|0|1|20110625||94^MMRV^CVX|999|||01^Historical^NIP001||||||Lot||||||A|ORC|RE||T77I668.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104634-0700||VXU^V04^VXU_V04|742380-C2.131.4252|D|2.5.1|PID|1||742380-C2.131^^^OIS-TEST^MR||Walcott^Harika^Lainey^^^^L||20091207|F||2106-3^White^HL70005|377 Humboldt Cir^^Rudyard^MI^49780^USA^P||^PRN^PH^^^906^6608472|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R08L669.1^OIS|RXA|0|1|20101207||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101207||||||F|ORC|RE||R08L669.2^OIS|RXA|0|1|20110701||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R08L669.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104634-0700||VXU^V04^VXU_V04|742380-C2.133.4780|D|2.5.1|PID|1||742380-C2.133^^^OIS-TEST^MR||Galveston^Shantay^Faylinn^^^^L||20091119|F||2131-1^Other Race^HL70005|68 Camp Ave^^Washington Township^MI^48095^USA^P||^PRN^PH^^^586^8584432|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A65U671.1^OIS|RXA|0|1|20101124||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||A65U671.2^OIS|RXA|0|1|20110625||141^Influenza^CVX|999|||01^Historical^NIP001||||||||^^||||A|ORC|RE||A65U671.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104635-0700||VXU^V04^VXU_V04|742380-C2.135.5276|D|2.5.1|PID|1||742380-C2.135^^^OIS-TEST^MR||McPherson^Bryna^^^^^L||20091123|F||1002-5^American Indian or Alaska Native^HL70005|119 Adams St^^Burton^MI^48509^USA^P||^PRN^PH^^^810^2964047|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Z45J673.1^OIS|RXA|0|1|20101123||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101123||||||F|ORC|RE||Z45J673.2^OIS|RXA|0|1|20110625||140^Influenza^CVX|999|||01^Historical^NIP001||||||||Lot #34TTY9||||A|ORC|RE||Z45J673.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104635-0700||VXU^V04^VXU_V04|742380-C2.136.5718|D|2.5.1|PID|1||742380-C2.136^^^OIS-TEST^MR||Alfalfa^Garrison^^^^^L||20091210|M||2106-3^White^HL70005|277 Jofray Cir^^Waterford Township^MI^48329^USA^P||^PRN^PH^^^248^9070544|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|20110506||Z30M674.1^OIS|RXA|0|1|20101206||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101206||||||F|ORC|RE||Z30M674.2^OIS|RXA|0|1|20110629||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z30M674.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104636-0700||VXU^V04^VXU_V04|742380-C2.137.6667|D|2.5.1|PID|1||742380-C2.137^^^OIS-TEST^MR||Hubbard^Ronnie^D^^^^L||20091122|F||2106-3^White^HL70005|134 Larssen Pl^^Traverse City^MI^49696^USA^P||^PRN^PH^^^231^7313009|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|UR||M91V675.1^OIS|RXA|0|1|20101120||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||M91V675.2^OIS|RXA|0|1|20110627||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M91V675.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104638-0700||VXU^V04^VXU_V04|742380-C3.001.8363|D|2.5.1||||PID|1||742380-C3.001^^^OIS-TEST^MR||Owen^Eunice^^^^^L||20091126|F||2131-1^Other Race^HL70005|94 Branch St^^Midland^MI^48642^USA^P||^PRN^PH^^^989^6532306|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K29A691.1^OIS|RXA|0|1|20101126||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101126||||||F|ORC|RE||K29A691.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K29A691.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104638-0700||VXU^V04^VXU_V04|742380-C3.005.8811|D|2.5.1||||AL|PID|1||742380-C3.005^^^OIS-TEST^MR||Dawson^Avel^Oscar^^^^L||20091201|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|66 Creaser Ln^^Emmett^MI^48022^USA^P||^PRN^PH^^^810^7541138|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||F30T695.1^OIS|RXA|0|1|20101208||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101208||||||F|ORC|RE||F30T695.2^OIS|RXA|0|1|20110704||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||F30T695.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W5169WY||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104639-0700||VXU^V04^VXU_V04|742380-C3.011.9604||2.5.1|PID|1||742380-C3.011^^^OIS-TEST^MR||Walsh^Tamir^V^^^^L||20091121|M||2106-3^White^HL70005|237 Wayne St^^Mid Michigan Reg Med Center^MI^48670^USA^P||^PRN^PH^^^989^2203199|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R57K701.1^OIS|RXA|0|1|20101118||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101118||||||F|ORC|RE||R57K701.2^OIS|RXA|0|1|20110624||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R57K701.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104640-0700||VXU^V04^VXU_V04|742380-C3.012.36|D|2.5.1|PID|1||742380-C3.012^^^OIS-TEST^MR||Seminole^Toker^^^^^L||20091205|M||2106-3^White^HL70005|197 Chippewa Ave^^Stephenson^MI^49887^USA^P||^PRN^PH^^^906^6336500|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||W51V702.1^OIS|RXA|0|1|20101203||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||W51V702.2^OIS|RXA|0|1|20110705||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W51V702.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104640-0700||VXU^V04^VXU_V04|742380-C3.013.500|D|2.5.1|PID|1||742380-C3.013^^^OIS-TEST^MR||Armstrong^Thordis^Noora^^^^L||20091123|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|164 Canadian Pl^^Pointe Aux Pins^MI^49775^USA^P||^PRN^PH^^^231^5247245|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||C82B703.1^OIS|RXA|0|1|20101128||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||C82B703.2^OIS|RXA|0|1|20110704||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C82B703.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104641-0700||VXU^V04^VXU_V04|742380-C3.014.1018|D|2.5.1|PID|1||742380-C3.014^^^OIS-TEST^MR||Gladwin^Frieda^Sondra^^^^L||20091202|F||1002-5^American Indian or Alaska Native^HL70005|229 Robertson Ave^^Grawn^MI^49637^USA^P||^PRN^PH^^^231^8767574|||||||||2186-5^not Hispanic or Latino^CDCREC|RXA|0|1|20101127||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||I01W704.1^OIS|RXA|0|1|20110630||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I01W704.2^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104641-0700||VXU^V04^VXU_V04|742380-C3.015.1450|D|2.5.1|PID|1||742380-C3.015^^^OIS-TEST^MR||Jakobsen^Charlee^Piltti^^^^L||20091211|F||1002-5^American Indian or Alaska Native^HL70005|156 Archer Ave^^Oakland^MI^48363^USA^P||^PRN^PH^^^248^9890973|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||V47L705.1^OIS|RXA|0|1|20101205||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||O6387ZU||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||V47L705.2^OIS|RXA|0|1|20110703||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||V47L705.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||O6387ZU||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104642-0700||VXU^V04^VXU_V04|742380-C3.016.2113|D|2.5.1|PID|1||742380-C3.016^^^OIS-TEST^MR||Duncan^Kaleo^N^^^^L||20091127|M||2106-3^White^HL70005|280 Knowles St^^Grand Rapids^MI^49506^USA^P||^PRN^PH^^^616^4018163|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||E62Q706.1^OIS|RXA|0|1|20101130||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101130||||||F|ORC|RE||E62Q706.2^OIS|RXA|0|1|20110703||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E62Q706.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104642-0700||VXU^V04^VXU_V04|742380-C3.017.2730|D|2.5.1|PID|1||742380-C3.017^^^OIS-TEST^MR||Marlin^Johannes^Leland^^^^L||20091129|M||2106-3^White^HL70005|329 Ellis Ave^^Springfield^MI^49015^USA^P||^PRN^PH^^^269^7054507|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S69H707.1^OIS|RXA|0||20101125||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101125||||||F|ORC|RE||S69H707.2^OIS|RXA|0|1|20110628||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S69H707.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104643-0700||VXU^V04^VXU_V04|742380-C3.018.3237|D|2.5.1|PID|1||742380-C3.018^^^OIS-TEST^MR||Brennan^Stacy^L^^^^L||20091207|M||2106-3^White^HL70005|182 Coleman Ln^^Christian Reformed Church^MI^49560^USA^P||^PRN^PH^^^616^6995298|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Williams^Ardis|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^This name is way too long for a city so long that it might cause some systems to crash as the max number of chars is fifty|^PRN^PH^^^616^6995298|ORC|RE||W32D708.1^OIS|RXA|0|1|20101201||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W1356FE||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||W32D708.2^OIS|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W32D708.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104643-0700||VXU^V04^VXU_V04|742380-C3.021.3989|D|2.5.1|PID|1||742380-C3.021^^^OIS-TEST^MR||Bernstrain^Minar^Standish^^^^L||20091121|M||2106-3^White^HL70005|269 Dickinson Cir^^Flint^MI^48557^USA^P||^PRN^PH^^^810^5300038|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Bernstrain^Evelin|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^^|^PRN^PH^^^810^5300038|ORC|RE||D38A711.1^OIS|RXA|0|1|20101128||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||D38A711.2^OIS|RXA|0|1|20110701||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D38A711.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104644-0700||VXU^V04^VXU_V04|742380-C3.023.4429|D|2.5.1|PID|1||742380-C3.023^^^OIS-TEST^MR||Reynolds^Daku^L^^^^L||20091207|M||2054-5^Black or African-American^HL70005|18 Fox Pl^^Grand Rapids^MI^49599^USA^P||^PRN^PH^^^616^8226428|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Roach^Cristy|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|[STREET] Apt 21|^PRN^PH^^^616^8226428|ORC|RE||B48X713.1^OIS|RXA|0|1|20101210||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||J6702KP||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101210||||||F|ORC|RE||B48X713.2^OIS|RXA|0|1|20110704||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||B48X713.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104644-0700||VXU^V04^VXU_V04|742380-C3.024.4854|D|2.5.1|PID|1||742380-C3.024^^^OIS-TEST^MR||Otoe^Marlon^L^^^^L||20091211|M||2106-3^White^HL70005|33 Gladwin St^^Wells^MI^49894^USA^P||^PRN^PH^^^906^4224609|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Lee^Bron|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^|^PRN^PH^^^906^4224609|ORC|RE||E83X714.1^OIS|RXA|0|1|20101205||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||E83X714.2^OIS|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E83X714.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104645-0700||VXU^V04^VXU_V04|742380-C3.025.5488|D|2.5.1|PID|1||742380-C3.025^^^OIS-TEST^MR||Iversen^Nic^H^^^^L||20091209|M||2106-3^White^HL70005|364 Erickson Pl^^Detroit^MI^48223^USA^P||^PRN^PH^^^313^2470023|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Iversen^Tenzin|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^|^PRN^PH^^^313^2470023|ORC|RE||W18C715.1^OIS|RXA|0|1|20101203||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||W18C715.2^OIS|RXA|0|1|20110703||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||W18C715.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104646-0700||VXU^V04^VXU_V04|742380-C3.027.6005|D|2.5.1|PID|1||742380-C3.027^^^OIS-TEST^MR||DeWitt^Panyin^Pompey^^^^L||20091116|M||2106-3^White^HL70005|237 Irving Ave^^Jenison^MI^49428^USA^P||^PRN^PH^^^616^8414314|||||||||2135-2^Hispanic or Latino^CDCREC|NK1|1|Perkins^Mayuri|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=|^^^^^^|^PRN^PH^^^616^8414314|ORC|RE||M65Z717.1^OIS|RXA|0|1|20101122||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||M65Z717.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M65Z717.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104646-0700||VXU^V04^VXU_V04|742380-C3.028.6731|D|2.5.1|PID|1||742380-C3.028^^^OIS-TEST^MR||Kenton^Argus^Cable^^^^L||20091205|M||2106-3^White^HL70005|364 Hardin Pl^^Lakeville^MI^48366^USA^P||^PRN^PH^^^248^5618491|||||||||2186-5^not Hispanic or Latino^CDCREC|NK1|1|Kenton^Purva|MTHNK1-3.2=MotherNK1-3.3=HL70063NK1-4.1=[STREET]NK1-4.3=[CITY]NK1-4.4=[STATE]NK1-4.5=[ZIP]NK1-4.6=USANK1-4.6=PNK1-5.1=||^PRN^PH^^^^|ORC|RE||O38W718.1^OIS|RXA|0|1|20101201||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||O38W718.2^OIS|RXA|0|1|20110630||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O38W718.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U5358SY||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104647-0700||VXU^V04^VXU_V04|742380-C3.033.7375|D|2.5.1|PID|1||742380-C3.033^^^OIS-TEST^MR||Stephens^Idris^T^^^^L||20091203|M||2106-3^White^HL70005|107 Sherman Pl^^Mackinac Island^MI^49757^^P||^PRN^PH^^^906^5664774|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||H56U723.1^OIS|RXA|0|1|20101209||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101209||||||F|ORC|RE||H56U723.2^OIS|RXA|0|1|20110705||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||H56U723.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P4849WV||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104648-0700||VXU^V04^VXU_V04|742380-C3.034.8137|D|2.5.1|PID|1||742380-C3.034^^^OIS-TEST^MR||Martin^Rex^Jaidev^^^^L||20091206|M||2106-3^White^HL70005|56 Lorain Pl^^Saint Heights^MI^48311^USA^P^^||^PRN^PH^^^586^9310381|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||F59I724.1^OIS|RXA|0|1|20101201||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||F59I724.2^OIS|RXA|0|1|20110629||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||F59I724.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104649-0700||VXU^V04^VXU_V04|742380-C3.035.9877|D|2.5.1|PID|1||742380-C3.035^^^OIS-TEST^MR||Harrison^Gloria^Cade^^^^L||20091127|F||2106-3^White^HL70005|333 Union Ln^^Mooreville^MI^48160^USA^P^^Apartment #25||^PRN^PH^^^734^5438111|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K62T725.1^OIS|RXA|0|1|20101128||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||K62T725.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||K62T725.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W5169WY||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104650-0700||VXU^V04^VXU_V04|742380-C3.036.781|D|2.5.1|PID|1||742380-C3.036^^^OIS-TEST^MR||Coconino^Aleksandra^L^^^^L||20091124|F||2054-5^Black or African-American^HL70005|62 O'Neill Cir^^Standale^MI^49534^USA^P||^PRN^PH^^^616^3181324|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S77R726.1^OIS|RXA|0|1|20101126||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101126||||||F|ORC|RE||S77R726.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S77R726.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104651-0700||VXU^V04^VXU_V04|742380-C3.038.1281|D|2.5.1|PID|1||742380-C3.038^^^OIS-TEST^MR||Wapello^Dani^Reine^^^^L||20091128|F||1002-5^American Indian or Alaska Native^HL70005|389 Holt Pl^^Grand Rapids^MI^49508^USA^P||^PRN^PH^^^616^8752063|||||||||2186-5^not Hispanic or Latino^CDCREC|||2|ORC|RE||R08S728.1^OIS|RXA|0|1|20101129||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||R08S728.2^OIS|RXA|0|1|20110705||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R08S728.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104652-0700||VXU^V04^VXU_V04|742380-C3.039.2061|D|2.5.1|PID|1||742380-C3.039^^^OIS-TEST^MR||Montgomery^Brabantio^Ivan^^^^L||20091123|M||1002-5^American Indian or Alaska Native^HL70005|330 Gallia Ln^^Richland^MI^49083^USA^P||^PRN^PH^^^269^3019903|||||||||2135-2^Hispanic or Latino^CDCREC||||ORC|RE||E56C729.1^OIS|RXA|0|1|20101118||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101118||||||F|ORC|RE||E56C729.2^OIS|RXA|0|1|20110624||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||E56C729.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104652-0700||VXU^V04^VXU_V04|742380-C3.041.2834|D|2.5.1|PID|1||742380-C3.041^^^OIS-TEST^MR||Columbia^Evan^Marquis^^^^L||20091130|M||2106-3^White^HL70005|67 McKinnon Cir^^Karlin^MI^49643^USA^P||^PRN^PH^^^231^4680039|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||D21O731.1^OIS|RXA|0|1|20101202||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||D21O731.2^OIS|RXA|0|1|20110706||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||D21O731.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S2309FF||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104653-0700||VXU^V04^VXU_V04|742380-C3.042.3334|D|2.5.1|PID|1||742380-C3.042^^^OIS-TEST^MR||Centre^Forster^K^^^^L||20091205|M||1002-5^American Indian or Alaska Native^HL70005|278 Webster Cir^^Kawkawlin^MI^48631^USA^P||^PRN^PH^^^989^5689470|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||L31N732.1^OIS|RXA|0|1|20101129||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||F9956NG||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||L31N732.2^OIS|RXA|0|1|20110624||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||L31N732.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104654-0700||VXU^V04^VXU_V04|742380-C3.043.4317|D|2.5.1|PID|1||742380-C3.043^^^OIS-TEST^MR||Bonneville^Clayland^P^^^^L||20091116|M||2131-1^Other Race^HL70005|74 Vistanst Pl^^Morenci^MI^49256^USA^P||^PRN^PH^^^517^9616818|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||S97V733.1^OIS|RXA|0|1|20101120||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||S97V733.2^OIS|RXA|0|1|20110624||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S97V733.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104654-0700||VXU^V04^VXU_V04|742380-C3.045.4770|D|2.5.1|PID|1||742380-C3.045^^^OIS-TEST^MR||Karlsson^Nivedita^Rishbha^^^^L||20091208|F||2106-3^White^HL70005|335 Marquette Ln^^Farmingtn Hls^MI^48331^USA^P||^PRN^PH^^^248^4746504|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||G92R735.1^OIS|RXA|0|1|20101201||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||G92R735.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G92R735.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104655-0700||VXU^V04^VXU_V04|742380-C3.048.5293|D|2.5.1|PID|1||742380-C3.048^^^OIS-TEST^MR||Sutherns^Noe^Myer^^^^||20091127|M||2106-3^White^HL70005|57 Floyd Ave^^Sand Creek^MI^49279^USA^P||^PRN^PH^^^517^3209089|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A41W738.1^OIS|RXA|0|1|20101125||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101125||||||F|ORC|RE||A41W738.2^OIS|RXA|0|1|20110702||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A41W738.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104655-0700||VXU^V04^VXU_V04|742380-C3.049.5767|D|2.5.1|PID|1||742380-C3.049^^^OIS-TEST^MR||Hanson^Erene^Wilga^^^^L||20091128|F||2106-3^White^HL70005|348 Kenedy St^^Baldwin^MI^49304^USA^P||^^^^^^|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R39N739.1^OIS|RXA|0|1|20101128||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||R39N739.2^OIS|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R39N739.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104656-0700||VXU^V04^VXU_V04|742380-C3.050.6325|D|2.5.1|PID|1||742380-C3.050^^^OIS-TEST^MR||Wilson^Juma^^^^^L||20091119|M||2106-3^White^HL70005|391 Wolfe Pl^^Detroit^MI^48234^USA^P||(313)8115193^PRN^^^^313^8115193|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||P39U740.1^OIS|RXA|0|1|20101121||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101121||||||F|ORC|RE||P39U740.2^OIS|RXA|0|1|20110628||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P39U740.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104657-0700||VXU^V04^VXU_V04|742380-C3.051.7270|D|2.5.1|PID|1||742380-C3.051^^^OIS-TEST^MR||Andersen^Summer^B^^^^L||20091124|F||2106-3^White^HL70005|170 Bastrop Pl^^Gr Blanc^MI^48439^USA^P||(810)9280226^^PH^^^810^9280226|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||O74W741.1^OIS|RXA|0|1|20101126||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101126||||||F|ORC|RE||O74W741.2^OIS|RXA|0|1|20110625||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||O74W741.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104657-0700||VXU^V04^VXU_V04|742380-C3.052.7768|D|2.5.1|PID|1||742380-C3.052^^^OIS-TEST^MR||Browne^Netty^V^^^^L||20091213|F||2106-3^White^HL70005|87 Lorain Ln^^Au Sable^MI^48750^USA^P||^PRN^PH^^^989^7784021|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||R55T742.1^OIS|RXA|0|1|20101208||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101208||||||F|ORC|RE||R55T742.2^OIS|RXA|0|1|20110701||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||R55T742.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5629BK||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104658-0700||VXU^V04^VXU_V04|742380-C3.053.8554|D|2.5.1|PID|1||742380-C3.053^^^OIS-TEST^MR||Kittitas^Cissy^Catalina^^^^L||20091208|F||2054-5^Black or African-American^HL70005|261 Pacific Ave^^Detroit^MI^48232^USA^P||^PRN^PH^^^313^3576154|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||B34X743.1^OIS|RXA|0|1|20101201||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||B34X743.2^OIS|RXA|0|1|20110627||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||B34X743.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G6456OT||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104659-0700||VXU^V04^VXU_V04|742380-C3.055.9001|D|2.5.1|PID|1||742380-C3.055^^^OIS-TEST^MR||Dallas^Hasad^Brant^^^^L||20091123|M||2106-3^White^HL70005|246 Del Norte Ln^^Farwell^MI^48622^USA^P||^PRN^PH^^^989^8146401|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||M12F745.1^OIS|RXA|0|1|20101124||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101124||||||F|ORC|RE||M12F745.2^OIS|RXA|0|1|20110626||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||M12F745.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104659-0700||VXU^V04^VXU_V04|742380-C3.056.9735|D|2.5.1|PID|1||742380-C3.056^^^OIS-TEST^MR||Hygens^Baldwin^Toker^^^^L||20091121|M||2028-9^Asian^HL70005|252 Lamar Ln^^Mi Department of Revenue^MI^48956^USA^P||^PRN^PH^^^517^6187372|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||I21K746.1^OIS|RXA|0|1|20101126||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101126||||||F|ORC|RE||I21K746.2^OIS|RXA|0|1|20110630||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||I21K746.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104701-0700||VXU^V04^VXU_V04|742380-C3.058.1104|D|2.5.1|PID|1||742380-C3.058^^^OIS-TEST^MR||Guernsey^Cossette^Arabella^^^^L||20091209|F||2106-3^White^HL70005|356 Clinton Ln^^Union Pier^MI^49129^USA^P||^PRN^PH^^^269^2001209|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||T88N748.1^OIS|RXA|0|1|20101212||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101212||||||F|ORC|RE||T88N748.2^OIS|RXA|0|1|20110707||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||T88N748.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104701-0700||VXU^V04^VXU_V04|742380-C3.060.1631|D|2.5.1|PID|1||742380-C3.060^^^OIS-TEST^MR||Bryan^Salvatore^F^^^^L||20091123|M||2106-3^White^HL70005|129 Bakey Pl^^Rodney^MI^49342^USA^P||^PRN^PH^^^231^3800288|||||||||2186-5^not Hispanic or Latino^CDCREC|PV1|1|R||||||||||||||||||V02|ORC|RE||H05M750.1^OIS|RXA|0|1|20101118||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101118||||||F|ORC|RE||H05M750.2^OIS|RXA|0|1|20110623||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||H05M750.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B9779LU||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104702-0700||VXU^V04^VXU_V04|742380-C3.062.2064|D|2.5.1|PID|1||742380-C3.062^^^OIS-TEST^MR||Stanton^Barak^Derren^^^^L||20091129|M||2106-3^White^HL70005|84 Kane Ln^^Flint^MI^48553^USA^P||^PRN^PH^^^810^7949527|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||B30U752.1^OIS|RXA|0|1|20101129||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||E5987IG||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101129||||||F|ORC|RE||B30U752.2^OIS|RXA|0|1|20110626||140^Influenza^CVX|999|||01^Historical^NIP001|||||||||||||ORC|RE||B30U752.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104702-0700||VXU^V04^VXU_V04|742380-C3.063.2556|D|2.5.1|PID|1||742380-C3.063^^^OIS-TEST^MR||Ross^Annabelle^Catalin^^^^L||20091119|F||2028-9^Asian^HL70005|214 Modoc Pl^^Harsens Island^MI^48028^USA^P||^PRN^PH^^^810^7525932|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||F37M753.1^OIS|RXA|0|1|20101119||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z8623GP||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101119||||||F|ORC|RE||F37M753.2^OIS|RXA|0|1|20110624||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||F37M753.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F9956NG||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104703-0700||VXU^V04^VXU_V04|742380-C3.065.3325|D|2.5.1|PID|1||742380-C3.065^^^OIS-TEST^MR||Clark^Rosario^Harshita^^^^L||20091125|F||2106-3^White^HL70005|65 Adair Ave^^Mackinac Island^MI^49757^USA^P||^PRN^PH^^^906^7356022|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||H01P755.1^OIS|RXA|0|1|20101122||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||H01P755.2^OIS|RXA|0|1|20110625||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||D|ORC|RE||H01P755.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104703-0700||VXU^V04^VXU_V04|742380-C3.066.3834|D|2.5.1|PID|1||742380-C3.066^^^OIS-TEST^MR||Pittsburg^Riley^H^^^^L||20091129|F||2106-3^White^HL70005|247 Wayne Pl^^Grand Rapids^MI^49515^USA^P||^PRN^PH^^^616^5197461|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||K40H756.1^OIS|RXA|0|1|20101205||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||K40H756.2^OIS|RXA|0|1|20110702||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||U|ORC|RE||K40H756.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K1608IF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104704-0700||VXU^V04^VXU_V04|742380-C3.067.4666|D|2.5.1|PID|1||742380-C3.067^^^OIS-TEST^MR||Cambria^Regis^Aviv^^^^L||20091123|M||2106-3^White^HL70005|291 Oneida Pl^^Woodhaven^MI^48183^USA^P||^PRN^PH^^^734^4338459|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||C82T757.1^OIS|RXA|0|1|20101122||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||C82T757.2^OIS|RXA|0|1|20110626||998^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C82T757.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104705-0700||VXU^V04^VXU_V04|742380-C3.068.5189|D|2.5.1|PID|1||742380-C3.068^^^OIS-TEST^MR||La Salle^Kingsley^Kiyoshi^^^^L||20091126|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|54 Santa Clara Cir^^Harbert^MI^49115^USA^P||^PRN^PH^^^269^4896045|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||C62Y758.1^OIS|RXA|0|1|20101125||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101125||||||F|ORC|RE||C62Y758.2^OIS|RXA|0|1|20110624||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C62Y758.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104705-0700||VXU^V04^VXU_V04|742380-C3.072.5653|D|2.5.1|PID|1||742380-C3.072^^^OIS-TEST^MR||Wheeler^Elissa^L^^^^L||20091120|F||2106-3^White^HL70005|104 Jackson Ave^^Spring Lake^MI^49456^USA^P||^PRN^PH^^^616^3325077|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||R57A762.1^OIS|RXA|0|1|20101120||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101120||||||F|ORC|RE||R57A762.2^OIS|RXA|0|1|20110624||140^Influenza^CVX||ML^^ISO+||01^Historical^NIP001||||||||||||A|ORC|RE||R57A762.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104706-0700||VXU^V04^VXU_V04|742380-C3.073.6103|D|2.5.1|PID|1||742380-C3.073^^^OIS-TEST^MR||Roberts^Alayah^Zoey^^^^L||20091208|F||2106-3^White^HL70005|20 Morrow Ln^^Sheridan^MI^48884^USA^P||^PRN^PH^^^989^4737949|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||S55L763.1^OIS|RXA|0|1|20101209||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||J6702KP||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101209||||||F|ORC|RE||S55L763.2^OIS|RXA|0|1|20110705||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||S55L763.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104706-0700||VXU^V04^VXU_V04|742380-C3.074.6840|D|2.5.1|PID|1||742380-C3.074^^^OIS-TEST^MR||Westport^Kenwyn^Rizpah^^^^L||20091122|F||2106-3^White^HL70005|84 Madison St^^Duck Lake^MI^49284^USA^P||^PRN^PH^^^517^4543213|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||F83W764.1^OIS|RXA|0|1|20101122||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||F83W764.2^OIS|RXA|0|1|20110624||140^Influenza^CVX|0|ML^^ISO+||01^Historical^NIP001||||||||||||A|ORC|RE||F83W764.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5300VX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104707-0700||VXU^V04^VXU_V04|742380-C3.075.7389|D|2.5.1|PID|1||742380-C3.075^^^OIS-TEST^MR||Carroll^Adalgiso^Keyon^^^^L||20091126|M||2106-3^White^HL70005|234 Ashland Ave^^Grosse Pointe Farms^MI^48230^USA^P||^PRN^PH^^^313^6836765|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||A53E765.1^OIS|RXA|0|1|20101203||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y9789ZR||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||A53E765.2^OIS|RXA|0|1|20110629||94^MMRV^CVX|0.5|^^||01^Historical^NIP001||||||||||||A|ORC|RE||A53E765.3^OIS|RXA|0|1|20131130||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104707-0700||VXU^V04^VXU_V04|742380-C3.076.7879|D|2.5.1|PID|1||742380-C3.076^^^OIS-TEST^MR||Gosper^Valletta^^^^^L||20091128|F||2131-1^Other Race^HL70005|238 Grundy Ln^^Kendall^MI^49062^USA^P||^PRN^PH^^^269^2705777|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||P42V766.1^OIS|RXA|0|1|20101205||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||K5094SC||SKB^GlaxoSmithKline^MVX||||A|RXR|^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||P42V766.2^OIS|RXA|0|1|20110707||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P42V766.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104708-0700||VXU^V04^VXU_V04|742380-C3.077.8313|D|2.5.1|PID|1||742380-C3.077^^^OIS-TEST^MR||Clark^Maitryi^Leigh^^^^L||20091206|F||1002-5^American Indian or Alaska Native^HL70005|79 Calaveras Cir^^Bay Port^MI^48720^USA^P||^PRN^PH^^^989^6266396|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||F02H767.1^OIS|RXA|0|1|20101202||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101202||||||F|ORC|RE||F02H767.2^OIS|RXA|0|1|20110628||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||F02H767.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||T9119YJ||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104708-0700||VXU^V04^VXU_V04|742380-C3.078.8788|D|2.5.1|PID|1||742380-C3.078^^^OIS-TEST^MR||Twin Falls^Blythe^^^^^L||20091206|F||2106-3^White^HL70005|150 Harrison Pl^^Brownstown Township^MI^48134^USA^P||^PRN^PH^^^734^8195396|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||G30U768.1^OIS|RXA|0|1|20101204||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B4624RX||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||G30U768.2^OIS|RXA|0|1|20110629||94^MMRV^CVX|999|||01^Historical^NIP001|||||||||00^Parental Decision|||A|ORC|RE||G30U768.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104709-0700||VXU^V04^VXU_V04|742380-C3.079.9234|D|2.5.1|PID|1||742380-C3.079^^^OIS-TEST^MR||Williams^Nico^Brynmor^^^^L||20091128|M||2106-3^White^HL70005|81 Montague Pl^^Riverdale^MI^48877^USA^P||^PRN^PH^^^989^2357219|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||P46F769.1^OIS|RXA|0|1|20101204||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||P46F769.2^OIS|RXA|0|1|20110703||141^Influenza^CVX|999|||01^Historical^NIP001|||||||||^||CP|A|ORC|RE||P46F769.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104709-0700||VXU^V04^VXU_V04|742380-C3.080.9929|D|2.5.1|PID|1||742380-C3.080^^^OIS-TEST^MR||Biela^Lisle^S^^^^L||20091206|M||2028-9^Asian^HL70005|379 Clermont Ln^^Pullman^MI^49450^USA^P||^PRN^PH^^^269^7508909|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||P09O770.1^OIS|RXA|0|1|20101206||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S2309FF||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101206||||||F|ORC|RE||P09O770.2^OIS|RXA|0|1|20110704||03^MMR^CVX|999|||01^Historical^NIP001|||||||||^||NA|A|ORC|RE||P09O770.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104710-0700||VXU^V04^VXU_V04|742380-C3.081.402|D|2.5.1|PID|1||742380-C3.081^^^OIS-TEST^MR||Antelope^Eustacia^Avera^^^^L||20091129|F||2106-3^White^HL70005|293 Taylor Cir^^Detroit^MI^48225^USA^P||^PRN^PH^^^313^6349466|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||B52I771.1^OIS|RXA|0|1|20101205||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||B52I771.2^OIS|RXA|0|1|20110703||141^Influenza^CVX|999|||01^Historical^NIP001|||||||||^||PA|A|ORC|RE||B52I771.3^OIS|RXA|0|1|20131130||94^MMRV^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104710-0700||VXU^V04^VXU_V04|742380-C3.082.846|D|2.5.1|PID|1||742380-C3.082^^^OIS-TEST^MR||Mercer^Heledd^Newlyn^^^^L||20091127|F||2106-3^White^HL70005|87 Imperial Cir^^Minden^MI^48456^USA^P||^PRN^PH^^^989^7207782|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||D42M772.1^OIS|RXA|0|1|20101128||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||T4667QS||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101128||||||F|ORC|RE||D42M772.2^OIS|RXA|0|1|20110629||140^Influenza^CVX|999|||01^Historical^NIP001|||||||||^||RE|A|ORC|RE||D42M772.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z1364WM||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104712-0700||VXU^V04^VXU_V04|742380-C3.083.2680|D|2.5.1|PID|1||742380-C3.083^^^OIS-TEST^MR||Fayette^Ramon^Stephen^^^^L||20091121|M||2106-3^White^HL70005|335 Mendocino Ave^^Hancock^MI^49930^USA^P||^PRN^PH^^^906^7236873|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||A95A773.1^OIS|RXA|0|1|20101122||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W5169WY||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101122||||||F|ORC|RE||A95A773.2^OIS|||||||||||||||||||||||||^^HL70177|RXA|0|1|20110623||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||A95A773.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104714-0700||VXU^V04^VXU_V04|742380-C3.088.4300|D|2.5.1|PID|1||742380-C3.088^^^OIS-TEST^MR||Coke^Subhuja^L^^^^L||20091121|F||2106-3^White^HL70005|339 Burnet St^^Cannonsburg^MI^49317^USA^P||^PRN^PH^^^616^9780911|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||^OIS|RXA|0|1|20101127||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||G24B778.2^OIS|RXA|0|1|20110629||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||G24B778.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||M4229UI||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104715-0700||VXU^V04^VXU_V04|742380-C3.089.5073|D|2.5.1|PID|1||742380-C3.089^^^OIS-TEST^MR||Manistee^Fortuna^A^^^^L||20091126|F||1002-5^American Indian or Alaska Native^HL70005|122 Morrill St^^Little Lake^MI^49833^USA^P||^PRN^PH^^^906^5546511|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||Y71Z779.1^OIS|RXA|0|1|20101201||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D9080OG||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||Y71Z779.2^OIS|RXA|0|1|20110630||140^Influenza^CVX|999|||01^Historical^NIP001|^^^^^^^^^^^^^^^^^^^^^^|||||||||||A|ORC|RE||Y71Z779.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||D6992FF||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104715-0700||VXU^V04^VXU_V04|742380-C3.090.5601|D|2.5.1|PID|1||742380-C3.090^^^OIS-TEST^MR||McLean^Mariko^Neola^^^^L||20091202|F||1002-5^American Indian or Alaska Native^HL70005|138 Thiemer Ave^^Howard City^MI^49329^USA^P||^PRN^PH^^^231^3092315|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||^OIS|RXA|0|1|20101205||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||W7145UP||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101205||||||F|ORC|RE||C34F780.2^OIS|RXA|0|1|20110628||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||C34F780.3^OIS|RXA|0|1|20131130||21^Varicella^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104716-0700||VXU^V04^VXU_V04|742380-C3.091.6034|D|2.5.1|PID|1||742380-C3.091^^^OIS-TEST^MR||Simpson^Yadon^Hank^^^^L||20091207|M||2106-3^White^HL70005|234 Eliason Cir^^Ann Arbor Township^MI^48105^USA^P||^PRN^PH^^^734^2120088|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||^OIS|RXA|0|1|20101203||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||K4679SL||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101203||||||F|ORC|RE||P68J781.2^OIS|RXA|0|1|20110707||21^Varicella^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||P68J781.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N2685LR||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104716-0700||VXU^V04^VXU_V04|742380-C3.092.6483|D|2.5.1|PID|1||742380-C3.092^^^OIS-TEST^MR||Wahkiakum^Balbo^Colton^^^^L||20091122|M||2106-3^White^HL70005|113 Garza Ave^^Battle Creek^MI^49014^USA^P||^PRN^PH^^^269^7801930|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||T10E782.1^OIS|RXA|0|1|20101127||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101127||||||F|ORC|RE||T10E782.2^OIS|RXA|0|1|20110701||140^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||T10E782.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||I5706AW||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104716-0700||VXU^V04^VXU_V04|742380-C3.095.6949|D|2.5.1|PID|1||742380-C3.095^^^OIS-TEST^MR||Eriksson^Charlee^Euclea^^^^L||20091205|F||2106-3^White^HL70005|82 Androscoggin Pl^^Livonia^MI^48153^USA^P||^PRN^PH^^^734^3806382|||||||||2135-2^Hispanic or Latino^CDCREC|ORC|RE||Y43Y785.1^OIS|RXA|0|1|20101204||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S9733RC||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101204||||||F|ORC|RE||Y43Y785.2^OIS|RXA|0|1|20110703||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Y43Y785.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I6608LZ||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104717-0700||VXU^V04^VXU_V04|742380-C3.096.7576|D|2.5.1|PID|1||742380-C3.096^^^OIS-TEST^MR||Skagit^Sushmita^S^^^^L||20091111|F||2106-3^White^HL70005|293 Navajo Pl^^Amway Corp^MI^49356^USA^P||^PRN^PH^^^616^2801631|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|||Z33C786.1^OIS|RXA|0|1|20101118||03^MMR^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101118||||||F|ORC|RE||Z33C786.2^OIS|RXA|0|1|20110623||141^Influenza^CVX|999|||01^Historical^NIP001||||||||||||A|ORC|RE||Z33C786.3^OIS|RXA|0|1|20131130||140^Influenza^CVX|0.25|mL^milliliters^UCUM||00^Administered^NIP001||||||F2773LS||NOV^Novartis^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|140^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104718-0700||VXU^V04^VXU_V04|742380-C3.103.8188|D|2.5.1|PID|1||742380-C3.103^^^OIS-TEST^MR||Somerset^Delcine^Bette^^^^L||20091128|F||2028-9^Asian^HL70005|61 Clinton St^^Le Roy^MI^49655^USA^P||^PRN^PH^^^231^8414168|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||H18C793.1^OIS|RXA|0|1|20101201||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E3834QF||SKB^GlaxoSmithKline^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101201||||||F|ORC|RE||H18C793.2^OIS|RXA|0|1|20110626||03^MMR^CVX|999|||01^Historical^NIP001|||||||||^||RE|A|ORC|RE||H18C793.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||A1996ME||CSL^CSL Behring^MVX||||A|RXR|IM^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|MSH|^~\&|||||20131130104718-0700||VXU^V04^VXU_V04|742380-C3.105.8928|D|2.5.1|PID|1||742380-C3.105^^^OIS-TEST^MR||Edwards^Marvin^Layton^^^^L||20091206|M||2054-5^Black or African-American^HL70005|361 Lyon Cir^^Macomb Township^MI^48042^USA^P||^PRN^PH^^^586^8680582|||||||||2186-5^not Hispanic or Latino^CDCREC|ORC|RE||S33G795.1^OIS|RXA|0|1|20101211||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20101211||||||F|ORC|RE||S33G795.2^OIS|RXA|0|1|20110704||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A||ORC|RE||S33G795.3^OIS|RXA|0|1|20131130||141^Influenza^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||W0617DD||PMC^sanofi pasteur^MVX||||A|RXR|IM^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20131130|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|141^Inactivated Flu^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120702||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20131130||||||F|